81 results on '"Stephen K. Durham"'
Search Results
2. Contributors
- Author
-
Basel T. Assaf, Adam D. Aulbach, Virunya Bhat, Brad Bolon, William M. Bracken, Alys E. Bradley, Glenn H. Cantor, Kevin B. Donnelly, Elodie Drevon-Gaillot, Stephen K. Durham, Jeffery A. Engelhardt, Daniela Ennulat, James Fikes, John Reginald Foster, Kathleen Funk, Sibylle Gröters, Magali R. Guffroy, Silvia Guionaud, Katherine Hammerman, Carole Harbison, Claudia Harper, Christopher Hurst, Evan B. Janovitz, Kevin Keane, Stephanie Klein, Rebecca Kohnken, Michael W. Leach, Xiantang Li, René Meisner, Keith Nelson, Thomas Nolte, Arun R. Pandiri, Jonathan A. Phillips, Colin G. Rousseaux, Daniel G. Rudmann, Keegan C. Rudmann, Aaron M. Sargeant, JoAnn C.L. Schuh, A. Eric Schultze, Rani S. Sellers, James A. Swenberg, Eric Tien, John L. Vahle, Lyn M. Wancket, and Charles E. Wood
- Published
- 2023
3. Predicting the Genotoxicity of Secondary and Aromatic Amines Using Data Subsetting To Generate a Model Ensemble.
- Author
-
Brian E. Mattioni, Gregory W. Kauffman, Peter C. Jurs, Laura L. Custer, Stephen K. Durham, and Greg M. Pearl
- Published
- 2003
- Full Text
- View/download PDF
4. Atrioventricular Valvular Angiectasis in Sprague-Dawley Rats
- Author
-
M. G. Mense, Stephen K. Durham, Carla L. Bregman, P. C. Howroyd, Wendy J. Freebern, Jochen Woicke, Anthony M. Fletcher, Hengsheng Fang, R. W. Diters, and Vito G. Sasseville
- Subjects
Male ,0301 basic medicine ,medicine.medical_specialty ,Endothelium ,040301 veterinary sciences ,Heart Valve Diseases ,Angiectasis ,Rats, Sprague-Dawley ,Rodent Diseases ,0403 veterinary science ,03 medical and health sciences ,Internal medicine ,medicine ,Sprague dawley rats ,Animals ,Vascular Diseases ,cardiovascular diseases ,Heart valve ,Fetus ,Atrioventricular valve ,General Veterinary ,business.industry ,04 agricultural and veterinary sciences ,Anatomy ,Rats ,Ostium ,030104 developmental biology ,medicine.anatomical_structure ,cardiovascular system ,Cardiology ,Cusp (anatomy) ,Female ,business - Abstract
Subendothelial heart valve angiectasis has been reported in cows, dogs, pigs, rats, mice, and in human fetuses and newborns. We observed a high incidence (62 in 208 animals examined) of spontaneous angiectasis on the atrioventricular (AV) valves in 10– to 40–week-old Sprague-Dawley rats. The angiectasis was observed predominately on the septal cusp of the right AV valve and located near the AV ostium in 57 of 62 animals. Of the remaining 5 valvular angiectases, 2 were present on the parietal cusp of the right AV valve and 3 were on the left AV valve. The angiectases were single or multiple, ranging from 40 to 300 um in diameter and were characterized by light microscopy as blood-filled dilatations lined by endothelium. Spontaneously occurring abnormalities in normal laboratory animals, such as the spontaneous valvular angiectasis reported here, need to be differentiated from drug-related lesions.
- Published
- 2007
5. Predicting the Genotoxicity of Polycyclic Aromatic Compounds from Molecular Structure with Different Classifiers
- Author
-
Linnan He, Greg M. Pearl, Stephen K. Durham, Laura L. Custer, and Peter C. Jurs
- Subjects
Chemistry ,Stereochemistry ,General Medicine ,Toxicology ,medicine.disease_cause ,Linear discriminant analysis ,Rats ,Polar surface area ,SOS chromotest ,Structure-Activity Relationship ,Probabilistic neural network ,SOS Response (Genetics) ,Liver ,Models, Chemical ,Binary classification ,medicine ,Animals ,Cutoff ,Neural Networks, Computer ,Polycyclic Aromatic Hydrocarbons ,SOS Response, Genetics ,Biological system ,Genotoxicity ,Mutagens ,Probability - Abstract
Classification models were developed to provide accurate prediction of genotoxicity of 277 polycyclic aromatic compounds (PACs) directly from their molecular structures. Numerical descriptors encoding the topological, geometric, electronic, and polar surface area properties of the compounds were calculated to represent the structural information. Each compound's genotoxicity was represented with IMAX (maximal SOS induction factor) values measured by the SOS Chromotest in the presence and absence of S9 rat liver homogenate. The compounds' class identity was determined by a cutoff IMAX value of 1.25-compounds with IMAX > 1.25 in either test were classified as genotoxic, and the ones with IMAX < or = 1.25 were nongenotoxic. Several binary classification models were generated to predict genotoxicity: k-nearest neighbor (k-NN), linear discriminant analysis, and probabilistic neural network. The study showed k-NN to provide the highest predictive ability among the three classifiers with a training set classification rate of 93.5%. A consensus model was also developed that incorporated the three classifiers and correctly predicted 81.2% of the 277 compounds. It also provided a higher prediction rate on the genotoxic class than any other single model.
- Published
- 2003
6. Exaggerated hepatotoxicity of acetaminophen in mice lacking tumor necrosis factor receptor-1 Potential role of inflammatory mediators
- Author
-
Donna M. Dambach, Marion K. Gordon, Stephen K. Durham, Carol R. Gardner, Mary K. Bruno, Peihong Zhou, Jeffrey D. Laskin, Donald R. Gerecke, Debra L. Laskin, and Hawjyh Chiu
- Subjects
Male ,medicine.medical_specialty ,Time Factors ,medicine.medical_treatment ,Blotting, Western ,Nitric Oxide Synthase Type II ,Mice, Transgenic ,Toxicology ,Receptors, Tumor Necrosis Factor ,Nitric oxide ,Mice ,chemistry.chemical_compound ,Antigens, CD ,Internal medicine ,medicine ,Animals ,RNA, Messenger ,Acetaminophen ,Pharmacology ,Liver injury ,Dose-Response Relationship, Drug ,Reverse Transcriptase Polymerase Chain Reaction ,business.industry ,Nitrotyrosine ,Analgesics, Non-Narcotic ,medicine.disease ,Mice, Inbred C57BL ,CTGF ,Endocrinology ,Cytokine ,Liver ,chemistry ,Receptors, Tumor Necrosis Factor, Type I ,Enzyme Induction ,Cytokines ,Tumor necrosis factor alpha ,Tumor necrosis factor receptor 1 ,Chemical and Drug Induced Liver Injury ,Nitric Oxide Synthase ,business ,Injections, Intraperitoneal ,Signal Transduction ,medicine.drug - Abstract
Transgenic mice with a targeted disruption of the tumor necrosis factor receptor 1 (TNFR1) gene were used to analyze the role of TNF-alpha in pro- and anti-inflammatory mediator production and liver injury induced by acetaminophen. Treatment of wild-type mice with acetaminophen (300 mg/kg) resulted in centrilobular hepatic necrosis. This was correlated with expression of inducible nitric oxide synthase (NOS II) and nitrotyrosine staining of the liver. Expression of macrophage chemotactic protein-1 (MCP-1), KC/gro, interleukin-1beta (IL-1beta), matrix metalloproteinase-9 (MMP-9), and connective tissue growth factor (CTGF), inflammatory mediators known to participate in tissue repair, as well as the anti-inflammatory cytokine, interleukin-10 (IL-10), also increased in the liver following acetaminophen administration. TNFR1(-/-) mice were found to be significantly more sensitive to the hepatotoxic effects of acetaminophen than wild-type mice. This was correlated with more rapid and prolonged induction of NOS II in the liver and changes in the pattern of nitrotyrosine staining. Acetaminophen-induced expression of MCP-1, IL-1beta, CTGF, and MMP-9 mRNA was also delayed or reduced in TNFR1(-/-) mice relative to wild-type mice. In contrast, increases in IL-10 were more rapid and more pronounced. These data demonstrate that signaling through TNFR1 is important in inflammatory mediator production and toxicity induced by acetaminophen.
- Published
- 2003
7. Predicting the Genotoxicity of Secondary and Aromatic Amines Using Data Subsetting To Generate a Model Ensemble
- Author
-
Stephen K. Durham, Gregory W. Kauffman, Peter C. Jurs, Laura L. Custer, Greg M. Pearl, and Brian E. Mattioni
- Subjects
Quantitative structure–activity relationship ,Databases, Factual ,Nitrogen ,Chemical structure ,Quantitative Structure-Activity Relationship ,medicine.disease_cause ,Sensitivity and Specificity ,Polar surface area ,Search engine ,Computational chemistry ,Numerical descriptors ,medicine ,Animals ,Molecule ,Amines ,Chemistry ,General Medicine ,General Chemistry ,Rats ,Computer Science Applications ,SOS chromotest ,Models, Chemical ,Computational Theory and Mathematics ,Rat liver ,Environmental chemistry ,Algorithms ,Genotoxicity ,Mutagens ,Information Systems - Abstract
Binary quantitative structure-activity relationship (QSAR) models are developed to classify a data set of 334 aromatic and secondary amine compounds as genotoxic or nongenotoxic based on information calculated solely from chemical structure. Genotoxic endpoints for each compound were determined using the SOS Chromotest in both the presence and absence of an S9 rat liver homogenate. Compounds were considered genotoxic if assay results indicated a positive genotoxicity hit for either the S9 inactivated or S9 activated assay. Each compound in the data set was encoded through the calculation of numerical descriptors that describe various aspects of chemical structure (e.g. topological, geometric, electronic, polar surface area). Furthermore, five additional descriptors that focused on the secondary and aromatic nitrogen atoms in each molecule were calculated specifically for this study. Descriptor subsets were examined using a genetic algorithm search engine interfaced with a k-Nearest Neighbor fitness evaluator to find the most information-rich subsets, which ultimately served as the final predictive models. Models were chosen for their ability to minimize the total number of misclassifications, with special attention given to those models that possessed fewer occurrences of positive toxicity hits being misclassified as nontoxic (false negatives). In addition, a subsetting procedure was used to form an ensemble of models using different combinations of compounds in the training and prediction sets. This was done to ensure that consistent results could be obtained regardless of training set composition. The procedure also allowed for each compound to be externally validated three times by different training set data with the resultant predictions being used in a "majority rules" voting scheme to produce a consensus prediction for each member of the data set. The individual models produced an average training set classification rate of 71.6% and an average prediction set classification rate of 67.7%. However, the model ensemble was able to correctly classify the genotoxicity of 72.2% of all prediction set compounds.
- Published
- 2003
8. Reduced Hepatotoxicity of Acetaminophen in Mice Lacking Inducible Nitric Oxide Synthase: Potential Role of Tumor Necrosis Factor-α and Interleukin-10
- Author
-
Steven D. Cohen, Carol R. Gardner, Stephen K. Durham, Michael Sacco, Peihong Zhou, Debra L. Laskin, Jeffrey D. Laskin, Donald R. Gerecke, Marion K. Gordon, Donna M. Dambach, and Mary K. Bruno
- Subjects
Pharmacology ,medicine.medical_specialty ,Nitrotyrosine ,Connective tissue ,Biology ,Toxicology ,Acetaminophen ,Nitric oxide ,CTGF ,Nitric oxide synthase ,chemistry.chemical_compound ,medicine.anatomical_structure ,Endocrinology ,chemistry ,Internal medicine ,Knockout mouse ,medicine ,biology.protein ,Tumor necrosis factor alpha ,medicine.drug - Abstract
Macrophage-derived inflammatory mediators have been implicated in tissue injury induced by a number of hepatotoxicants. In the present studies, we used transgenic mice with a targeted disruption of the gene for inducible nitric oxide synthase (NOS II) to analyze the role of nitric oxide in inflammatory mediator production in the liver and in tissue injury induced by acetaminophen. Treatment of wild-type mice with acetaminophen (300 mg/kg) resulted in centrilobular hepatic necrosis, which was evident within 3 h and reached a maximum at 18 h. This was correlated with NOS II expression and nitrotyrosine staining of the liver, which was most prominent after 6 h. Expression of mRNA for tumor necrosis factor-α (TNF-α), interleukin-10 (IL-10), matrix metalloproteinase-9, and connective tissue growth factor (CTGF) also increased in the liver following acetaminophen treatment of wild-type mice. NOS II knockout mice were found to be less sensitive to the hepatotoxic effects of acetaminophen than wild-type mice. This did not appear to be due to differences in acetaminophen-induced glutathione depletion or adduct formation. In NOS II knockout mice treated with acetaminophen, hepatic expression of TNF-α, as well as CTGF, was significantly increased compared to wild-type mice. In contrast, IL-10 expression was reduced. These data demonstrate that nitric oxide is important in hepatotoxicity induced by acetaminophen. Moreover, some of its effects may be mediated by altering production of pro- and antiinflammatory cytokines and proteins important in tissue repair.
- Published
- 2002
9. Role of CCR2 in macrophage migration into the liver during acetaminophen-induced hepatotoxicity in the mouse
- Author
-
Stephen K. Durham, Linda Watson, Debra L. Laskin, Kevin R. Gray, and Donna M. Dambach
- Subjects
medicine.medical_specialty ,CCR2 ,Hepatology ,CD68 ,Inflammation ,Biology ,Acetaminophen ,Proinflammatory cytokine ,Endocrinology ,Internal medicine ,medicine ,Macrophage ,Tumor necrosis factor alpha ,medicine.symptom ,Receptor ,medicine.drug - Abstract
The biological effects of monocyte chemoattractant protein (MCP) 1 are mediated by binding to C-C chemokine receptor (CCR) 2. In the present studies, we used CCR2 knockout (CCR2-/-) mice to examine the role of MCP-1 in acetaminophen-induced macrophage accumulation in the liver, expression of inflammatory cytokines, and hepatotoxicity. We found that hepatic expression of CCR2 and MCP-1 was increased 10-fold and 20-fold, respectively, 12 to 72 hours after administration of acetaminophen to wild-type mice. Expression of these proteins was localized in centrilobular regions of the liver. Whereas MCP-1 was expressed by both hepatocytes and macrophages, CCR2 was identified in inflammatory macrophages. F4/80 is a marker of mature macrophages expressed in large quantities by Kupffer cells. In wild-type mice, a 75% decrease in F4/80-positive macrophages was observed 24 to 48 hours after administration of acetaminophen. In contrast, expression of macrosialin (CD68), a marker of activated macrophages, increased 2-fold 24 to 72 hours after administration of acetaminophen and was associated with inflammatory cells. Although there was a decrease in the overall severity of inflammation and in the number of macrosialin-positive macrophages 72 hours after administration of acetaminophen in CCR2-/- mice, the number of F4/80-positive cells did not change. Loss of CCR2 was also found to alter acetaminophen-induced expression of tumor necrosis factor alpha, monocyte chemoattractant protein 3, and KC/gro. However, the overall outcome of acetaminophen-induced hepatic injury was not affected. In conclusion, these data indicate that MCP-1 and CCR2 contribute to the recruitment of a subset of activated macrophages into the liver during acetaminophen-induced hepatotoxicity that may be important in resolution of tissue injury.
- Published
- 2002
10. Increased severity of glomerulonephritis in C-C chemokine receptor 2 knockout mice
- Author
-
Peter H. Gitlitz, Takao Kurihara, Mary Giancarli, Mark C. Kowala, Stephen K. Durham, Michele H. French, J.Eileen Bird, Maria T. Valentine, and Darshana G. Pandya
- Subjects
medicine.medical_specialty ,CCR2 ,Chemokine ,Receptors, CCR2 ,monocyte chemoattractant protein-1 ,Fluorescent Antibody Technique ,chemokines ,Mice ,Chemokine receptor ,chemistry.chemical_compound ,Glomerulonephritis ,Internal medicine ,Animals ,Medicine ,DNA Primers ,Mice, Knockout ,Creatinine ,Kidney ,Base Sequence ,biology ,business.industry ,nephrotoxic nephritis ,medicine.disease ,Immunohistochemistry ,Endocrinology ,medicine.anatomical_structure ,chemistry ,inflammation ,Nephrology ,Knockout mouse ,biology.protein ,Receptors, Chemokine ,business ,Nephritis - Abstract
Increased severity of glomerulonephritis in C-C chemokine receptor 2 knockout mice. Background The C-C chemokine receptor 2 (CCR2) is expressed on monocytes and facilitates monocyte migration. CCR2 is a prominent receptor for monocyte chemoattractant protein-1 (MCP-1). This chemokine recruits monocytes to sites of inflammation. It has been suggested that CCR2 and its ligand, MCP-1, play a role in the pathogenesis of glomerulonephritis. The goal of this study was to determine the contribution of CCR2 in a murine model of accelerated nephrotoxic nephritis. We measured the extent of development of renal disease in CCR2 wild-type and knockout mice after the administration of antiglomerular basement membrane antibody. Methods Eight groups of animals were treated ( N = 10 per group). Four days after IgG immunization, CCR2 wild-type and knockout mice received control serum or nephrotoxic serum. The urinary protein/creatinine ratio was measured on days 1 and 3; plasma and kidneys were collected on days 4 and 7. Kidneys were evaluated by light microscopy, immunohistochemistry, and immunofluorescence. The genotype of mice was confirmed by tissue analysis. Results Protective effects of CCR2 knockout on the urinary protein/creatinine ratio were observed on day 1, as values for this parameter were significantly lower (35 ± 3.6) than in nephritic wild-type mice (50 ± 6.8). There was a marked increase in proteinuria in nephritic wild-type mice on day 1 compared with vehicle-treated, wild-type animals (5 ± 1.0). On day 3, the ameliorative effects of CCR2 knockout were not observed; the increase in the urinary protein/creatinine ratio was similar in nephritic CCR2 wild-type (92 ± 11.2) and knockout mice (102 ± 9.2). Plasma markers of disease were evaluated on days 4 and 7. At these time points, there were no beneficial effects of CCR2 receptor knockout on plasma levels of urea nitrogen, creatinine, albumin, or cholesterol. On day 7, blood urea nitrogen (248 ± 19.9 mg/dL) and plasma cholesterol were higher in nephritic CCR2 knockout mice than in wild-type mice (142 ± 41.7 mg/dL) that received nephrotoxic serum. Histopathologic injury was more severe in nephritic CCR2 knockout mice than nephritic wild-type mice on day 4 (3.1 ± 0.3 vs. 2.0 ± 0.3) and day 7 (3.6 ± 0.2 vs. 2.9 ± 0.3). By immunohistochemical analysis at day 4, there were significantly fewer mac-2–positive cells, representative of macrophages in the glomeruli of nephritic CCR2 knockout (2.1 ± 0.6) mice than nephritic wild-type (3.9 ± 0.5) animals. By indirect immunofluorescence, there was a moderate, diffuse linear IgG deposition of equivalent severity present in glomeruli of both wild-type and CCR2 knockout nephritic mice. Conclusion These results suggest that our strategy was successful in reducing macrophage infiltration, but this model of glomerulonephritis is not solely dependent on the presence of CCR2 for progression of disease. After a transient ameliorative effect on proteinuria, CCR2 knockout led to more severe injury in nephritic mice. This raises the intriguing possibility that a CCR2 gene product ameliorates glomerulonephritis in this murine model. Although effects that occur in chemokine knockout mice are not equivalent to those expected with prolonged use of a chemokine antagonist, this study may nevertheless have implications for consideration of long-term use of chemokine antagonists in renal disease.
- Published
- 2000
11. Intranasal Toxicity of BMS-181885, A Novel 5-HT1 Agonist
- Author
-
Oliver P. Flint, Mark A. Dominick, James E. Proctor, Nuggehally R. Srinivas, Amy E. Weiss, Stephen K. Durham, Beth E. Schilling, and Gene E. Schulze
- Subjects
Pathology ,medicine.medical_specialty ,Necrosis ,Mucous membrane of nose ,Biology ,Pharmacology ,Toxicology ,medicine.anatomical_structure ,In vivo ,Toxicity ,medicine ,Respiratory epithelium ,Nasal administration ,medicine.symptom ,Olfactory epithelium ,Nose - Abstract
One-month intranasal toxicity studies were conducted with BMS-181885 at doses of 1.5, 9, or 15 mg/animal/day in rats and 4, 24, or 40 mg/animal/day in monkeys. A 1-month intermittent intranasal toxicity study was also conducted in monkeys at doses of 3, 6, and 12 mg/animal 3 days per week. BMS-181885 was generally well tolerated in rats but resulted in dose-dependent nasal mucosal injury, primarily characterized by subacute inflammation of the nasal mucosa, and degeneration, single-cell necrosis, and/or erosion of the olfactory epithelium and, to a lesser extent, the respiratory epithelium. In monkeys, daily BMS-181885 administration was well tolerated and produced similar dose-dependent nasal injury primarily characterized by subacute inflammation of the nasal mucosa with degeneration and erosion of the olfactory epithelium. In a separate experiment, intermittent administration also resulted in dose-dependent nasal injury. In cultured rat nasal mucosal cells, BMS-181885 was toxic to olfactory epithelial cells with a range of mean IC50s between 44 and 291 μM. In contrast, BMS-181885 had no effect on respiratory epithelial cells up to its maximum solubility. Cytochrome P450 inhibition had no effect on the toxicity of BMS-181885 in olfactory epithelial cells but produced dose-dependent toxicity in respiratory epithelial cells, which was not present previously. The in vitro data suggest that parent drug, rather than a toxic metabolite, caused the drug-associated nasal mucosal injury.
- Published
- 1999
12. Utilization of Genetically Altered Animals in the Pharmaceutical Industry
- Author
-
Stephen K. Durham and Daniel G. Rudmann
- Subjects
Knockout rat ,Drug Industry ,040301 veterinary sciences ,Transgene ,Drug Evaluation, Preclinical ,Mice, Transgenic ,Pharmacology ,Biology ,Toxicology ,Risk Assessment ,030226 pharmacology & pharmacy ,Pathology and Forensic Medicine ,0403 veterinary science ,Gene product ,Mice ,03 medical and health sciences ,0302 clinical medicine ,Animals ,Humans ,Molecular Biology ,Regulator gene ,Mice, Knockout ,Genetics ,Strain (biology) ,Proteins ,04 agricultural and veterinary sciences ,Cell Biology ,Genetically modified organism ,Disease Models, Animal ,Drug development ,Knockout mouse - Abstract
The study of transgenic and gene-deleted (knockout) mice provides important insights into the in vivo function and interaction of specific gene products. Within the pharmaceutical industry, genetically altered mice are used predominantly in discovery research to characterize the diverse functions of one or multiple gene products or to establish animal models of human disease for proof-of-concept studies. We recently used genetically altered animals in drug discovery to examine the NF-KB family of transcriptional regulatory genes and to elucidate their essential role in the early onset of immune and inflammatory responses. Transgenic and knockout mice are also useful in drug development, because questions regarding risk assessment and carcinogenesis, xenobiotic metabolism, receptor- and ligand-mediated toxicity, and immunotoxicity can be evaluated using these genetically altered mice. For example, the p53 knockout mouse is one of several genetically altered mice whose use may increase the sensitivity and decrease the time and cost of rodent carcinogenicity bioassays. As with any experimental model system, data obtained from genetically altered mice must be interpreted carefully. The complete inactivation of a gene may result in altered expression of related genes or physiologic compensation for the loss of the gene product. Consideration must also be given to the genetic background of the mouse strain and the impact of strain variability on disease or toxicity models. Despite these potential limitations, knockout mice provide a powerful tool for the advancement of drugs in the pharmaceutical industry.
- Published
- 1999
13. Nuclear Factor (NF)-κB2 (p100/p52) Is Required for Normal Splenic Microarchitecture and B Cell–mediated Immune Responses
- Author
-
Cheryl A. Rizzo, Rodrigo Bravo, Clifford M. Snapper, Carmen Raventos-Suarez, Jorge Caamano, Debra S. Barton, and Stephen K. Durham
- Subjects
Lipopolysaccharides ,T cell ,Immunology ,B-Lymphocyte Subsets ,Immunoglobulins ,Receptors, Antigen, B-Cell ,Bone Marrow Cells ,Spleen ,Biology ,Lymphocyte Activation ,Article ,Epitopes ,Mice ,Immune system ,NF-kappa B p52 Subunit ,Lymphopenia ,medicine ,Animals ,Immunology and Allergy ,CD40 Antigens ,B cell ,Mice, Knockout ,Immunity, Cellular ,Mice, Inbred ICR ,CD40 ,NF-kappa B ,Germinal center ,Articles ,Germinal Center ,NFKB1 ,Molecular biology ,Mice, Inbred C57BL ,Mutagenesis, Insertional ,medicine.anatomical_structure ,biology.protein ,Female ,Lymph Nodes ,Antibody ,Signal Transduction - Abstract
The nfkb2 gene is a member of the Rel/NF-kappa B family of transcription factors. COOH-terminal deletions and rearrangements of this gene have been associated with the development of human cutaneous T cell lymphomas, chronic lymphocytic leukemias, and multiple myelomas. To further investigate the function of NF-kappa B2, we have generated mutant mice carrying a germline mutation of the nfkb2 gene by homologous recombination. NF-kappa B2-deficient mice showed a marked reduction in the B cell compartment in spleen, bone marrow, and lymph nodes. Moreover, spleen and lymph nodes of mutant mice presented an altered architecture, characterized by diffuse, irregular B cell areas and the absence of discrete perifollicular marginal and mantle zones; the formation of secondary germinal centers in spleen was also impaired. Proliferation of NF-kappa B2-deficient B cells was moderately reduced in response to lipopolysaccharide, anti-IgD-dextran, and CD40, but maturation and immunoglobulin switching were normal. However, nfkb2 (-/-) animals presented a deficient immunological response to T cell-dependent and -independent antigens. These findings indicate an important role of NF-kappa B2 in the maintenance of the peripheral B cell population, humoral responses, and normal spleen architecture.
- Published
- 1998
14. Expression of Constitutively Active IκBβ in T Cells of Transgenic Mice: Persistent NF-κB Activity Is Required for T-Cell Immune Responses
- Author
-
Stephen K. Durham, Carmen Raventos-Suarez, Rodrigo Bravo, Ricardo M. Attar, and Heather Macdonald-Bravo
- Subjects
T-Lymphocytes ,T cell ,Transgene ,Population ,Mice, Transgenic ,Biology ,Lymphocyte Activation ,Mice ,chemistry.chemical_compound ,Immune system ,medicine ,Animals ,education ,Molecular Biology ,Transcriptional Regulation ,education.field_of_study ,Gene Transfer Techniques ,NF-kappa B ,NF-κB ,Cell Biology ,NFKB1 ,Molecular biology ,DNA-Binding Proteins ,medicine.anatomical_structure ,Gene Expression Regulation ,chemistry ,Mutation ,I-kappa B Proteins ,Cell activation ,CD8 - Abstract
The transcription factor NF-kappaB is normally sequestered in the cytoplasm by members of the IkappaB family, including IkappaB alpha, IkappaB beta, and the recently cloned IkappaB epsilon. Upon cellular activation, these inhibitors are rapidly phosphorylated on two amino-terminal serines, ubiquitinated, and degraded by the 26S proteasome, releasing a functional NF-kappaB. To determine the importance of IkappaB beta in NF-kappaB regulation in T cells, we generated transgenic mice expressing a constitutively active IkappaB beta mutant (mIkappaB beta) under the control of the lck promoter. The transgene contains the two critical N-terminal serine residues mutated to alanines and therefore no longer susceptible to degradation upon cell activation. mIkappaB beta is unable to totally displace IkappaB alpha from RelA-containing complexes, thus allowing a transient activation of NF-kappaB upon T-cell stimulation. However, mIkappaB beta completely blocks NF-kappaB activity after IkappaB alpha degradation. In addition, as a consequence of this inhibition, ikba expression is down regulated, along with that of other NF-kappaB-regulated genes. These transgenic mice have a significant reduction in the peripheral T-cell population, especially CD8+ cells. The remaining T cells have impaired proliferation in response to phorbol 12-myristate 13-acetate plus phytohemagglutinin or calcium ionophore but not to anti-CD3/anti-CD28 costimulation. As a result of these alterations, transgenic animals present defects in immune responses such as delayed-type hypersensitivity and the generation of specific antibodies against T-cell-dependent antigens. These results show that in nonstimulated T cells, IkappaB beta cannot efficiently displace IkappaB alpha bound to RelA-containing complexes and that persistent NF-kappaB activity is required for proper T-cell responses in vivo.
- Published
- 1998
15. Hypoxia stimulates human preproendothelin-1 promoter activity in transgenic mice
- Author
-
Suzanne Oparil, Yiu-Fai Chen, Catherine R. Aversa, Shuang-dan Sun, Alexander G. Minchenko, Jaime Caro, Stephen K. Durham, Thomas M. Monticello, M R Swerdel, Sergio A. Lira, Maria L. Webb, and Huaibin Li
- Subjects
Pulmonary and Respiratory Medicine ,Genetically modified mouse ,medicine.medical_specialty ,Transcription, Genetic ,Physiology ,Ratón ,Recombinant Fusion Proteins ,Mice, Transgenic ,Pulmonary Artery ,Biology ,Transfection ,Mice ,Genes, Reporter ,In vivo ,Physiology (medical) ,Internal medicine ,Gene expression ,medicine ,Animals ,Humans ,RNA, Messenger ,Protein Precursors ,Hypoxia ,Luciferases ,Promoter Regions, Genetic ,Lung ,Cells, Cultured ,Endothelin-1 ,Endothelins ,Promoter ,Cell Biology ,Hypoxia (medical) ,Endothelin 1 ,Endocrinology ,Cattle ,Endothelium, Vascular ,medicine.symptom ,Endothelin receptor - Abstract
Significant elevations in endothelin (ET)-1 levels accompany many diseases, but the underlying regulatory mechanisms are unclear. To investigate the in vivo regulation of human preproendothelin-1 (PPET-1), we examined the activity of the PPET-1 promoter in transgenic mice exposed to hypoxia. Mice expressing one of three PPET-1 promoter-luciferase (PPET-1/LUC) reporter transgenes (≈2.5 kb, 138 bp, or none of the 5′-flanking sequences of the PPET-1 gene) were generated. LUC expression was reduced in mice with a truncated 138-bp PPET-1 promoter. Exposure of mice bearing the 2.5-kb PPET-1/LUC transgene to hypoxia (10% O2for 24 h) increased LUC expression sixfold in pulmonary tissue but only twofold in other tissues. In situ hybridization revealed the strongest transgene expression in the pulmonary vasculature and bronchiolar epithelium. These data are consistent with the hypothesis that hypoxic induction of the PPET-1 gene leads to increased pulmonary production of ET-1 in diseases associated with low O2tension.
- Published
- 1997
16. Glucokinase Regulatory Protein May Interact With Glucokinase in the Hepatocyte Nucleus
- Author
-
Stephen S. Kalinowski, John R. Megill, Stephen K. Durham, Kasim A. Mookhtiar, and Karen S. Brown
- Subjects
Male ,Endocrinology, Diabetes and Metabolism ,Fructose ,Glucagon ,Immunoenzyme Techniques ,Rats, Sprague-Dawley ,chemistry.chemical_compound ,1-Methyl-3-isobutylxanthine ,Glucokinase ,Internal Medicine ,medicine ,Animals ,Humans ,Nuclear protein ,Adaptor Proteins, Signal Transducing ,Cell Nucleus ,Glucokinase regulatory protein ,biology ,Liver cell ,Intracellular Signaling Peptides and Proteins ,Proteins ,Cell Compartmentation ,Rats ,medicine.anatomical_structure ,Liver ,chemistry ,Biochemistry ,Cytoplasm ,Hepatocyte ,biology.protein ,Carrier Proteins - Abstract
Glucokinase (GK) plays a central role in the sensing of glucose in pancreatic β-cells and parenchymal cells of the liver. Glucokinase regulatory protein is a physiological inhibitor of GK in the liver. To understand the role of the interaction of these two proteins in glucose sensing, we carried out a series of experiments to localize the protein in the liver cell. The regulatory protein was found to be present mainly in the nucleus of the cell under a variety of conditions that mimicked the glucose status of the fed and fasted state. GK was localized in the nucleus when the cells were exposed to low glucose concentrations. At higher glucose concentrations or in the presence of low concentrations of fructose, GK translocated to the cytoplasm. The effect of fructose was more robust and rapid than the effect of high glucose concentrations. Furthermore, the effect of fructose and high glucose on the translocation of GK from the nucleus could be partially reversed by glucagon. This unusual localization and behavior suggests a role for GK and its regulatory protein in hepatic energy metabolism that may be broader than glucose phosphorylation.
- Published
- 1997
17. Contributors
- Author
-
E. Terence Adams, Rick Adler, Carl L. Alden, Phillip M. Bartholomew, Joydeep Basu, Val R. Beasley, Brian R. Berridge, Timothy A. Bertram, Hyo-eun Bhang, Hugh E. Black, Brad Bolon, Gary A. Boorman, Denise I. Bounous, Rogely Waite Boyce, William M. Bracken, Amy E. Brix, Danielle Brown, Mark T. Butt, Glenn H. Cantor, Bruce D. Car, Vincent Castranova, Russell C. Cattley, Curtis Chan, Robert E. Chapin, Samuel M. Cohen, Steve Colegate, Daniel Cook, Paul S. Cooke, Torrie A. Crabbs, Dianne M. Creasy, James W. Crissman, John M. Cullen, Dimitry M. Danilenko, Barbara Davis, Myrtle A. Davis, T. Zane Davis, Ronald A. DeLellis, Nancy D. Denslow, Kelly L. Diegel, David C. Dorman, Richard R. Dubielzig, Stephen K. Durham, Sandy Eldridge, Susan A. Elmore, Jeffrey I. Everitt, Suzanne Fenton, Duncan C. Ferguson, Reuel Field, George L. Foley, William R. Foster, Jerry D. Frantz, Kathy Gabrielson, Shayne C. Gad, Elizabeth J. Galbreath, Dale R. Gardner, Robert H. Garman, Santokh Gill, Peter Glerup, Dale L. Goad, Mary Elizabeth Pecquet Goad, Nanna Grand, Benjamin T. Green, Kathryn E. Gropp, Hans Jørgen G. Gundersen, Diane Gunson, Ramesh C. Gupta, Sharon M. Gwaltney-Brant, Jeffery O. Hall, Wendy Halpern, Gordon C. Hard, Jerry F. Hardisty, Jack R. Harkema, Philip W. Harvey, Wanda M. Haschek, Kathleen Heinz-Taheny, Ronald A. Herbert, Eugene Herman, Mark Hoenerhoff, Ann Hubbs, David Hutto, Evan B. Janovitz, Kanwar Nasir M. Khan, Kevin P. Keenan, Roy L. Kerlin, John M. Kreeger, Kannan Krishnan, C. Frieke Kuper, Stephen T. Lee, Lois D. Lehman-McKeeman, Xiantang Li, Eric D. Lombardini, Calvert Louden, John W. Ludlow, David E. Malarkey, Peter C. Mann, Robert R. Maronpot, Kevin S. McDorman, Mark A. Melanson, Robert Mercer, Rosanna Mirabile, Ronald W. Moch, James P. Morrison, Daniel Morton, Laura Dill Morton, Sureshkumar Muthupalani, Kristen J. Nikula, Ricardo Ochoa, Michelle E. Pacheco-Thompson, Olga M. Pulido, Kip E. Panter, George A. Parker, Dale W. Porter, Douglas Reid Patterson, James A. Pfister, Carl A. Pinkert, Lila Ramaiah, Deepa B. Rao, Donald G. Robertson, Jennifer Rojko, Thomas J. Rosol, Colin G. Rousseaux, Daniel G. Rudmann, Christine Ruehl-Fehlert, Linda Sargent, Christina M. Satterwhite, Kenneth A. Schafer, Philip F. Solter, Robert C. Sills, Liz Simon, Mikala Skydsgaard, Graham S. Smith, Krishnan Sriram, Bryan L. Stegelmeier, John M. Sullivan, Catherine Sutcliffe, James A. Swenberg, Polina Sysa-Shah, Leandro Teixeira, Noriko Tsuchiya, John L. Vahle, John F. Van Vleet, Aurore Varela, Kenneth A. Voss, Robin M. Walker, Matthew A. Wallig, Gail L. Walter, Kevin D. Welch, Paul White, Christopher T. Winkelmann, Zbigniew W. Wojcinski, and Jeffrey C. Wolf
- Published
- 2013
18. Risk Assessment
- Author
-
James A. Swenberg and Stephen K. Durham
- Subjects
Risk analysis (engineering) ,Process (engineering) ,Computer science ,Human exposure ,Adverse health effect ,Mechanism based ,Hazard analysis ,Risk assessment ,Variety (cybernetics) ,Exposure assessment - Abstract
Risk assessment is the systematic analysis of scientific data to characterize potential adverse health effects resulting from human exposure to hazardous agents or situations. Classical risk assessment is composed of four major components, including hazard identification, dose–response evaluation, exposure assessment, and risk characterization. This assessment relies on a wide variety of data sources of both a qualitative and a quantitative nature. Classical default-based risk assessment is evolving into a science-based risk assessment process that more fully utilizes mechanistic data. The integrative analysis of toxicogenomic-derived data into this process has favorably impacted the risk assessment landscape.
- Published
- 2013
19. Utilization of Electron Probe Microanalysis in Gadolinium-Treated Mice
- Author
-
Stephen K. Durham, Peter H. Gitlitz, Thomas M. Monticello, Arthur J. Wasserman, and Robert S. Feldman
- Subjects
Male ,0301 basic medicine ,Pathology ,medicine.medical_specialty ,040301 veterinary sciences ,Phagocytosis ,Gadolinium ,chemistry.chemical_element ,Kidney ,Toxicology ,Bone canaliculus ,Pathology and Forensic Medicine ,law.invention ,0403 veterinary science ,Mice ,03 medical and health sciences ,law ,medicine ,Animals ,Lung ,Molecular Biology ,Endoplasmic reticulum ,Kupffer cell ,04 agricultural and veterinary sciences ,Cell Biology ,Mononuclear phagocyte system ,Subcellular localization ,030104 developmental biology ,medicine.anatomical_structure ,Liver ,chemistry ,Electron microscope ,Spleen ,Electron Probe Microanalysis - Abstract
Gadolinium is used as a contrast media for magnetic resonance imaging and, experimentally, to block Kupffer cell phagocytosis. In this study, we utilize electron probe microanalysis to determine the subcellular localization of gadolinium chloride (GdCl 3) administered to mice in a short-term toxicology study. Male CD-1 mice were administered 0.0, 2.5, or 8.0 mg/kg GdCl3 iv for 14 consecutive weekdays. Liver-associated enzymes were significantly elevated in high-dose animals only and correlated histologically with multifocal, hepatocellular degeneration associated with a neutrophilic infiltrate. Morphological investigations were performed on high-dose animals. Hepatocytes and Kupffer cells had morphologic features of cellular injury consisting of swollen mitochondria and vesiculated profiles of endoplasmic reticulum. Hepatocytes, Kupffer cells, bile canaliculi, and neutrophils in the liver contained discrete aggregates of electron-dense granular material, as did pulmonary interstitial macrophages, splenic macrophages, and mesangial cells of the renal glomerulus. The intracellular granular material in the liver, lung, spleen, and kidney was confirmed as gadolinium by qualitative electron probe microanalysis. These results document both hepatic and extra-hepatic accumulation of gadolinium in cells of the mononuclear phagocytic system and highlight the importance of electron probe microanalysis in toxicologic assessment.
- Published
- 1996
20. Neutrophil infiltration, glial reaction, and neurological disease in transgenic mice expressing the chemokine N51/KC in oligodendrocytes
- Author
-
James Loy, Sergio A. Lira, Richard M. Ransohoff, Rodrigo Bravo, John W. Peterson, Maria Elena Fuentes, Bruce D. Trapp, Stephen K. Durham, and Marie Tani
- Subjects
Male ,Chemokine ,Pathology ,Neutrophils ,Chemokine CXCL1 ,Restriction Mapping ,Polymerase Chain Reaction ,Mice ,Growth Substances ,Promoter Regions, Genetic ,Mice, Inbred ICR ,biology ,Brain ,General Medicine ,Oligodendroglia ,medicine.anatomical_structure ,Mice, Inbred DBA ,Cytokines ,Intercellular Signaling Peptides and Proteins ,Neuroglia ,Female ,Chemokines ,Chemokines, CXC ,Infiltration (medical) ,Research Article ,Genetically modified mouse ,medicine.medical_specialty ,Recombinant Fusion Proteins ,Transgene ,Molecular Sequence Data ,Posture ,Central nervous system ,Mice, Transgenic ,medicine ,Animals ,DNA Primers ,Base Sequence ,Chemotactic Factors ,Myelin Basic Protein ,Chemotaxis ,medicine.disease ,Introns ,Myelin basic protein ,Mice, Inbred C57BL ,Microscopy, Electron ,Astrocytes ,Immunology ,biology.protein ,Nervous System Diseases - Abstract
Chemokines (pro-inflammatory chemoattractant cytokines) are expressed in pathological conditions of the central nervous system (CNS). Previous studies suggested that the CNS is relatively resistant to leukocyte diapedesis after chemokine injection, leaving their functional role unresolved. The CNS function of N51/KC, a neutrophil-selective chemokine, was addressed by expressing N51/KC under control of the myelin basic protein (MBP) promoter in transgenic (tg) mice (MBP-N51/KC mice). CNS-specific N51/KC expression produced remarkable neutrophil infiltration into perivascular, meningeal, and parenchymal sites, demonstrating that this chemokine exerts the multiple functions in vivo required to recruit leukocytes into the CNS. MBP-N5 1/KC mice represent an incisive model for the molecular dissection of neutrophil entry into the CNS. Unexpectedly, MBP-N51/KC mice developed a neurological syndrome of pronounced postural instability and rigidity at high frequency beginning at 40 days of age, well after peak chemokine expression. 68/182 mice in one tg fine were found dead before one year of age, with prominent neurological symptoms premortem in 26 (38%). Florid microglial activation and blood-brain barrier disruption without dysmyelination were the major neuropathological alterations. Late-onset neurological symptoms in MBP-N51/KC mice may indicate unanticipated consequences of CNS chemokine expression.
- Published
- 1996
21. A ferret model of electrical-induction of arterial thrombosis that is sensitive to aspirin
- Author
-
John R. Megill, William A. Schumacher, Thomas E. Steinbacher, and Stephen K. Durham
- Subjects
Blood Platelets ,Male ,Platelet Aggregation ,Thromboxane ,In Vitro Techniques ,Pharmacology ,Toxicology ,Vascular occlusion ,Fibrin ,Rats, Sprague-Dawley ,Thromboxane A2 ,Species Specificity ,medicine ,Animals ,Humans ,Vasoconstrictor Agents ,Platelet ,Thrombus ,Oxazoles ,Whole blood ,Aspirin ,biology ,business.industry ,Ferrets ,Thrombosis ,Bridged Bicyclo Compounds, Heterocyclic ,medicine.disease ,Electric Stimulation ,Prostaglandin Endoperoxides, Synthetic ,Rats ,Disease Models, Animal ,Microscopy, Electron ,Carotid Arteries ,Regional Blood Flow ,15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid ,Anesthesia ,Microscopy, Electron, Scanning ,Prothrombin Time ,biology.protein ,Collagen ,medicine.symptom ,Carotid Artery Injuries ,business ,Platelet Aggregation Inhibitors ,medicine.drug - Abstract
An experimental model of acute thrombosis was developed in pentobarbital-anesthetized ferrets. A 10-min anodal electrical stimulation of 1 mA was delivered to the external surface of the carotid artery while measuring carotid blood flow (CBF). This produced an occlusive thrombus in all vehicle-treated ferrets within 41 ± 3 min with an average weight of 8 ± 1 mg ( n = 7). These thrombi were enriched in both platelets and fibrin and were adherent at the site of transmural vascular injury as determined by light and electron microscopy. To determine the model's sensitivity to antiplatelet drugs, aspirin or a thromboxane (TxA 2 ) receptor antagonist (ifetroban) were administered 15 min before electrical stimulation. Thrombus weight was reduced 58% by aspirin (10 mg/kg, i.v.) and 74% by ifetroban (1 mg/kg + 1 mg/kg per hr, i.v.). Both drugs also improved CBF and decreased vascular occlusion. Ferrets were more sensitive than rats to aspirin's inhibition of collagen-induced platelet aggregation as determined ex vivo in whole blood. Separate in vitro platelet aggregation studies revealed species differences in reactivity to U-46619 (TxA 2 receptor agonist) and collagen in the order of human > ferret > rat, with relatively lesser variations in ADP responses. These studies identify the ferret as a useful species for evaluating antithrombotic drugs in a model in which aspirin is efficacious.
- Published
- 1996
22. Orally Active Endothelin Receptor Antagonist BMS-182874 Suppresses Neointimal Development in Balloon-Injured Rat Carotid Arteries
- Author
-
Maria T. Valentine, Nancy L. Goller, Tonya Jenkins-West, Stephen K. Durham, Helen Weber, Patricia Ferrer, Christopher J. Molloy, and Suzanne Moreland
- Subjects
Endothelin Receptor Antagonists ,Male ,medicine.medical_specialty ,Vascular smooth muscle ,medicine.drug_class ,Administration, Oral ,Muscle, Smooth, Vascular ,Catheterization ,Rats, Sprague-Dawley ,Lesion ,Restenosis ,Internal medicine ,medicine ,Animals ,Receptor ,Dansyl Compounds ,Pharmacology ,Receptors, Endothelin ,Endothelin receptor antagonist ,business.industry ,Antagonist ,DNA ,Receptor, Endothelin A ,medicine.disease ,Receptor antagonist ,Receptor, Endothelin B ,Rats ,Carotid Arteries ,Endocrinology ,medicine.symptom ,Cardiology and Cardiovascular Medicine ,Endothelin receptor ,business ,Cell Division - Abstract
Vascular smooth muscle cell (SMC) proliferation is an important component in the development of restenosis. Because endothelin (ET) has been reported to act as an SMC mitogen, we postulated that the orally active ET A receptor antagonist BMS-182874 would suppress the development of the intimal lesion that develops in rat carotid arteries after balloon injury. Using cultured rat aortic SMC, we noted that ET-1-stimulated increases in [ 3 H]thymidine incorporation were blocked by BMS-182874. To determine the effect of the drug on intimal lesion formation, we treated rats with BMS-182874 (100 mg/kg orally, p.o.) or vehicle once daily for 3 weeks, beginning 1 week before balloon injury. Two weeks after injury, drug-treated rats had a 35% decrease in lesion area and a 34% decrease in the lesion/media ratio as compared with the vehicle-treated rats. In situ hybridization (ISH) analysis of balloon-injured rat carotid arteries showed an increase in ET A receptor mRNA. These data support the concept that ET A receptor activation contributes to intimal lesion formation by promotion of SMC proliferation and suggest a potential use for ET A receptor antagonists in the amelioration of hyperproliferative vascular diseases, including restenosis.
- Published
- 1995
23. Comparison of Acute Hepatocellular Proliferating Cell Nuclear Antigen Labeling Indices and Growth Fractions, p34cdc2 Kinases, and Serum Enzymes in Carbon Tetrachloride-Treated Rats
- Author
-
Xinfang Ma, Debra S. Barton, John G. Babish, Thomas M. Monticello, and Stephen K. Durham
- Subjects
Male ,040301 veterinary sciences ,Sorbitol dehydrogenase ,CCL4 ,Toxicology ,030226 pharmacology & pharmacy ,S Phase ,Pathology and Forensic Medicine ,Rats, Sprague-Dawley ,0403 veterinary science ,03 medical and health sciences ,0302 clinical medicine ,Western blot ,Cyclin-dependent kinase ,Proliferating Cell Nuclear Antigen ,CDC2 Protein Kinase ,Mitotic Index ,medicine ,Animals ,Aspartate Aminotransferases ,Carbon Tetrachloride ,Molecular Biology ,biology ,medicine.diagnostic_test ,Kinase ,Cell growth ,Alanine Transaminase ,04 agricultural and veterinary sciences ,Cell Biology ,Cell cycle ,Immunohistochemistry ,Molecular biology ,Cyclin-Dependent Kinases ,Rats ,Proliferating cell nuclear antigen ,Liver ,Biochemistry ,biology.protein - Abstract
We evaluated various biomarkers associated with cell proliferation immediately following insult with the classic hepatotoxicant carbon tetrachloride (CCl4). Rats were administered a single necrogenic dose of CCl4 and euthanized at either t = 4, 8, 12, 16, or 24 hr postdose. Parameters evaluated included the following: immunohistochemical detection of hepatocellular proliferating cell nuclear antigen labeling indices (PCNA-LIs; percentage of cells in S phase) and growth fractions (PCNA-GFs; percentage of cells in the cell cycle); PCNA and the cyclin-dependent kinase p34cdc2 (CDK) protein in S-9 fractions by Western blot and enzyme-linked immunosorbent assay (ELISA); and liver-related serum enzymes. An increase in PCNA-GF was observed at t = 4 hr, concomitant with elevations in CDK and PCNA protein (Western blot). PCNA-LIs were increased by t = 24 hr, as were CDK and PCNA by ELISA. Sorbitol dehydrogenase was the most sensitive enzyme, with increases observed at t = 4 hr. Our results indicate that PCNA-GF, CDK, and PCNA levels reflect hepatocellular regeneration as early as 4 hr following CCl4 insult. We conclude that these assays are early and sensitive indicators of acute hepatotoxicity that may be advantageous to evaluate in the early stages of exploratory studies.
- Published
- 1995
24. Hepatic nitric oxide production following acute endotoxemia in rats is mediated by increased inducible nitric oxide synthase gene expression
- Author
-
Nancy L. Goller, Jeffrey D. Laskin, Diane E. Heck, Shaw‐Min Hwang, Stephen K. Durham, Debra L. Laskin, S. Tsuyoshi Ohnishi, and Marina Rodriguez Del Valle
- Subjects
medicine.medical_specialty ,Hepatology ,biology ,Arginine ,Lipopolysaccharide ,Nitric oxide ,Nitric oxide synthase ,chemistry.chemical_compound ,medicine.anatomical_structure ,Endocrinology ,chemistry ,Apoptosis ,Internal medicine ,Hepatocyte ,medicine ,biology.protein ,Tumor necrosis factor alpha ,Hepatocyte growth factor ,medicine.drug - Abstract
In the present studies, we analyzed the effects of acute endotoxemia on hepatocyte nitric oxide production and functional activity. Treatment of rats with 5 mg/kg of lipopolysaccharide (LPS), which induces acute endotoxemia, caused an increase in nitric oxide production in the liver, as measured by electron paramagnetic spin trapping, which was evident within 6 hours. This was associated with expression of inducible nitric oxide synthase (iNOS) messenger (m) RNA in hepatocytes and in sinusoidal cells throughout the liver lobule. Acute endotoxemia also caused alterations in hepatic structure, including hypertrophy, vacuolization, and chromosomal emargination, however these changes were not apparent for 24 to 48 hours. Hepatocytes isolated from endotoxemic rats released increased amounts of nitric oxide, measured by nitrite production, in response to interferon gamma (γ-IFN) alone or in combination with LPS, tumor necrosis factor alpha, macrophage-colony stimulating factor, granulocyte/macrophage-colony stimulating factor, or hepatocyte growth factor. These results show that hepatocytes are sensitized by acute endotoxemia to respond to inflammatory mediators and growth factors. Increased nitrite production by hepatocytes was due to increased expression of iNOS mRNA and protein and was correlated with the time following induction of acute endotoxemia. Thus, cells isolated 48 hours after induction of acute endotoxemia released significantly more nitrite than cells recovered after 6 hours, a response that was not due to alterations in hepatocyte viability. Hepatocytes isolated from endotoxemic rats also exhibited a marked increase in proliferative capacity when compared with cells from control rats. Nitric oxide production by hepatocytes in vitro was associated with inhibition of cell growth and protein synthesis, which was reversed by the nitric oxide synthase inhibitor, N G -monomethyl- l -arginine (L-NMMA). Agarose gel electrophoresis showed extensive cytoplasmic DNA fragmentation in hepatocytes treated with LPS and γ-IFN, a characteristic of apoptosis, which was also reversed by L-NMMA. These results, together with our findings that treatment of rats with an inhibitor of nitric oxide synthase partially reversed the structural alterations in the liver associated with acute endotoxemia suggest that nitric oxide may contribute to the pathophysiologic response to this bacterially derived toxin.
- Published
- 1995
25. Comparison of a Novel ETA Receptor Antagonist and Phosphoramidon in Renal Ischemia
- Author
-
Eileen Bird, Eddie C.-K. Liu, Maria L. Webb, Mary Giancarli, Jay Wasserman, and Stephen K. Durham
- Subjects
Pharmacology ,chemistry.chemical_compound ,chemistry ,Renal ischemia ,Endothelin receptor antagonist ,ETA Receptor Antagonist ,Phosphoramidon ,General Medicine ,Endothelin receptor - Abstract
Infusion (0.46 µmol/kg/min) of the endothelin (ET)-converting-enzyme inhibitor, phosphoramidon (P), protected function and structure after 30 min renal ischemia in rats more than treatment (5 µmol/kg/
- Published
- 1995
26. Effects of Antithrombotic Drugs in a Rat Model of Aspirin-Insensitive Arterial Thrombosis
- Author
-
W A Schumacher, Stephen K. Durham, John R. Megill, T E Steinbacher, and C.L. Heran
- Subjects
medicine.medical_specialty ,Aspirin ,business.industry ,medicine.drug_class ,Anticoagulant ,Warfarin ,Hematology ,Pharmacology ,medicine.disease ,Thrombosis ,Surgery ,Dipyridamole ,Medicine ,Platelet ,Thrombus ,Ticlopidine ,business ,medicine.drug - Abstract
SummaryThese studies describe experimental conditions where aspirin is less effective than other antiplatelet and anticoagulant drugs in inhibiting acute arterial thrombosis. External electrolytic injury of the rat carotid artery was used to induce occlusive thrombi in 97% of vehicle-treated rats. Thrombi were revealed by light and electron microscopy to be comprised primarily of platelets enmeshed in a fibrin network. The thrombin inhibitor D-phenylalanyl-L-prolyl-L-arginyl chloromethy ketone (PPACK; 6 mg/kg, i. v.) decreased thrombus weight by 90%. Aspirin alone (1, 10 and 30 mg/kg, i. v.), dipyridamole alone (5 mg/kg i. v.) and aspirin (1 and 10 mg/kg, i. v.) in combination with dipyridamole (5 mg/kg, i. v.) did not inhibit thrombosis. The platelet-activating factor (PAF) antagonist, WEB 2086, (1 mg/kg i. v.) was also ineffective. Other drugs had intermediate activity. Thrombi were decreased 56% by the thromboxane receptor antagonist, BMS 180,291, either alone (5.8 mg/kg i.v.) or in combination with aspirin (10 mg/kg, i.v.). Heparin (900 U/kg, i.v.), warfarin (0.25 mg/kg, p.o. once daily for 3 days) and ticlopidine (200 mg/ kg, p.o. once daily for 3 days) reduced thrombus weight by 63, 73 and 43% respectively. Reductions in thrombus weight were always associated with improvements in either average blood flow or vessel patency.
- Published
- 1993
27. Comparison of a Thromboxane Receptor Antagonist and Aspirin in Experimental Arterial Thrombosis
- Author
-
William A. Schumacher, I. Michel, Stephen K. Durham, C.L. Heran, John R. Megill, and S. Youssef
- Subjects
Blood Platelets ,Male ,Thromboxane ,Receptors, Thromboxane ,Prostaglandin ,Pharmacology ,Rats, Sprague-Dawley ,Thromboxane A2 ,chemistry.chemical_compound ,Physiology (medical) ,Antithrombotic ,Animals ,Medicine ,Platelet ,Aspirin ,biology ,Heparin ,business.industry ,Antagonist ,Thrombosis ,Hematology ,Rats ,Thromboxane B2 ,Microscopy, Electron ,chemistry ,Anesthesia ,biology.protein ,Drug Therapy, Combination ,Partial Thromboplastin Time ,Thromboxane-A synthase ,business ,medicine.drug - Abstract
The antithrombotic activities of aspirin, the thromboxane (Tx) A2/prostaglandin endoperoxide-receptor (TP-receptor) antagonist, SQ 30,741, and heparin were determined in anesthetized rats. Heparin (3 doses of 50, 300 U/kg), aspirin (1 and 10 mg/ kg), SQ 30,741 (1 mg/kg + 1 mg/kg/h), or the combination of SQ 30,741 and aspirin (10 mg/kg) was administered intravenously before inducing occlusive thrombosis with 0.1-mA stimulation of the intimal surface of the carotid artery. Light and electron microscopy revealed the thrombi to be composed predominately of platelets enmeshed in a fibrin network. Heparin (300 U/kg), SQ 30,741 and SQ 30,741 + aspirin decreased average thrombus weight by 54, 57 and 39%, respectively. These treatments also reduced the incidence of occlusion and improved carotid blood flow during thrombosis. In contrast, aspirin alone (1 and 10 mg/kg) and the lower heparin dose (50 U/ kg) did not significantly affect thrombus weight or carotid blood flow. To verify adequate drug dosage, pharmacological activities were characterized ex vivo in separate rats. Aspirin (10 mg/kg) inhibited maximum thromboxane (Tx) B2 production in whole blood by 99 ± 1 % and SQ 30,741 blocked 96% of platelet TP-receptors. Heparin increased the activated partial thromboplastin time (APTT) partially at 50 U/kg (∼ 3-fold) and maximally at 300 U/kg ( > 10-fold). These experiments demonstrate the contribution of platelet and coagulation mechanisms to a thrombosis model which is sensitive to a TP-receptor antagonist, but not aspirin.
- Published
- 1993
28. On the Fibrinolytic System in Aged Rats, and Its Reactivity to Endotoxin and Cytokines
- Author
-
Stephen K. Durham, R.J. Barelds, T. Kooistra, J.J. Emeis, M.A. Horan, and A. Brouwer
- Subjects
medicine.medical_specialty ,Lung ,Platelet aggregation ,business.industry ,medicine.medical_treatment ,Microgram ,Hematology ,Plasma levels ,Endocrinology ,Cytokine ,medicine.anatomical_structure ,Internal medicine ,Fibrinolysis ,medicine ,Tumor necrosis factor alpha ,business ,Plasminogen activator - Abstract
SummaryAged rats are more susceptible to endotoxin-induced effects, including microthrombosis and platelet aggregation, than are young rats. To investigate whether changes in the fibrinolytic system might be involved, we investigated the fibrinolytic activity in plasma euglobulin fractions and tissues (lung and heart) of young (6-months old) and aged (24-months old) rats under baseline conditions and after challenge with endotoxin. Aged rats had lower plasma levels of tissue-type plasminogen activator (t-PA) and of urokinase-type PA (u-PA) activity. PA inhibitor (PAI) activity was higher in the plasma of aged rats, as was t-PA activity in lung and heart.Rats were treated with either a low dose (1 μg/kg) or a high dose (10 mg/kg) of endotoxin. Both treatments induced a transient phase of increased blood fibrinolytic activity, as evidenced by higher levels of tissue-type plasminogen activator (t-PA) activity and decreased levels of PA inhibitor (PAI) activity. Over time, the fibrinolytic activity decreased, probably due to increased levels of PA inhibitor.Both the early increase in t-PA activity, and the subsequent increase in PAI activity, were more pronounced in the aged rats, as compared with the younger rats, after the high dose of endotoxin. The aged rats also responded to an injection of interleukin-1β or tumor necrosis factor-α with a larger increase of PAI activity than did the younger rats.Together the data suggest that, compared to young rats, aged rats have a decreased base-line plasma fibrinolytic activity, while their fibrinolytic system is more responsive to challenge by endotoxin and cytokines.
- Published
- 1992
29. Effects of polychlorinated biphenyls in rat liver: Correlation between primary subcellular effects and promoting activity
- Author
-
Michael Schwarz, Albrecht Buchmann, Stephen K. Durham, Susanne Ziegler, Larry W. Robertson, and Armin Wolf
- Subjects
medicine.medical_specialty ,Toxicology ,chemistry.chemical_compound ,Cytochrome P-450 Enzyme System ,Internal medicine ,medicine ,Animals ,Diethylnitrosamine ,Carcinogen ,Adenosine Triphosphatases ,Pharmacology ,chemistry.chemical_classification ,biology ,Chemistry ,Body Weight ,Cytochrome P450 ,Rats, Inbred Strains ,Organ Size ,gamma-Glutamyltransferase ,Polychlorinated Biphenyls ,Rats ,Endocrinology ,Enzyme ,Liver ,Mechanism of action ,Enzyme Induction ,Toxicity ,Carcinogens ,Microsome ,biology.protein ,Female ,Phenobarbital ,medicine.symptom ,Xenobiotic ,Subcellular Fractions ,medicine.drug - Abstract
In the present study the promoting activity of various PCB and PBB isomers and congeners in rat liver has been studied and compared with a variety of primary xenobiotic-mediated enzymatic changes in this target organ. Female Wistar rats were given diethylnitrosamine (DEN; 10 mg/kg body wt for 10 days) and were subsequently treated once weekly with polychlorinated biphenyls (150 or 15 μmol/kg body wt) for a total of 8 weeks. Additional groups of rats were administered 3,3′,4,4′-tetrabromobiphenyl or 3-methylcholanthrene (8 weekly injections of 15 or 150 μmol/kg body wt, respectively) or were given phenobarbital (0.05% in the diet) until the end of the experiment. Reference groups were treated with the various test compounds without prior initiation. One week and 9 weeks after cessation of promoter treatment rats were killed and the volumetric fraction of enzyme-altered foci characterized by changes in adenosine triphosphatase and γ-glutamyl transpeptidase activity was determined as a means to quantitatively assess the extent of preneoplastic response in this organ. Out of the series of polyhalogenated biphenyls tested, promoting effects were seen with the following compounds: 2,2′,4,5′-tetrachlorobiphenyl, 3,3′,4,4′-tetrachlorobiphenyl, 2,3,4,4′,5-pentachlorobiphenyl, and 3,3′,4,4′-tetrabromobiphenyl, whereas no significant effects were obtained with 4-monochlorobiphenyl. In rats not treated with DEN, the two strongly promoting agents 2,3,4,4′,5-pentachloribiphenyl and 3,3′,4,4′-tetrachlorobiphenyl also significantly increased the volume fraction of enzyme-altered foci over the respective controls when analyzed at the second time point of investigation. In parallel experiments, induction of liver growth and of microsomal cytochrome P450 content in liver was found to correlate well with the promoting activity of the various xenobiotics, suggesting that these parameters may be used to predict the promoting activity of polyhalogenated biphenyls in a short term assay.
- Published
- 1991
30. Time course of testicular degeneration in rats induced by a synthetic retinoid (Ro 23-2895) and evidence for induction of hypovitaminosis A in the testes
- Author
-
Thomas Bosakowski, Stephen K. Durham, and Arthur A. Levin
- Subjects
Male ,Germinal epithelium ,medicine.medical_specialty ,medicine.drug_class ,Administration, Oral ,Tretinoin ,Testicle ,Biology ,Toxicology ,chemistry.chemical_compound ,Internal medicine ,Testis ,medicine ,Animals ,Testosterone ,Retinoid ,Spermatogenesis ,Vitamin A ,Vitamin A Deficiency ,Anti-Inflammatory Agents, Non-Steroidal ,Retinol ,Rats, Inbred Strains ,Sertoli cell ,Sperm ,Rats ,medicine.anatomical_structure ,Endocrinology ,chemistry - Abstract
Eight-week-old male Sprague—Dawley rats were dosed by gavage with 90 mg/kg of Ro 23-2895, (all-E) -9[2-(nonyloxy) phenyl]-3,7-dimethyl-2,4,6,8 nonatetraenoic acid, dissolved in Tween 80. Treated animals ( n = 3−4) were sacrificed after 3,7,11, and 21 days of dosing. Control rats ( n = 3) received an equal volume of Tween 80 and were sacrificed after 3 or 21 days. Cross sections of formalin fixed testes were embedded in glycolmethacrylate, sectioned at 3 μm, and stained with periodic acid-Schiff and hematoxylin. No morphologic alterations were observed in the control rats or in treated rats after 3 days. After 7 days of treatment, there were occasional tubules in which there was a delayed release of mature sperm and occasionally the retained sperm were being resorbed. The frequency and severity of these morphologic changes was increased after 11 days of treatment, and round spermatids were occasionally observed with marginated chromatin in their nuclei. After 21 days of treatment, there was a significant reduction in testicular weight accompanied by marked degenerative changes and in some cases almost a complete desquamation of the germinal epithelium. Multinucleated giant cells and germ cells with marginated chromatin in their nuclei were commonly observed and there was moderate to severe oligospermiain the tubules. Sertoli cell nuclei were swollen and showed lucent, vesiculated nucleoplasm. In a parallel 21-day study, treated rats ( n = 10) showed an 80% reduction in plasma retinol and a 56% decrease in testicular retinol compared to vehicle-treated rats ( n = 10). A 53% decrease in plasma testosterone levels was also observed in treated rats. The testicular lesions produced by treatment with Ro 23-2895 were similar to vitamin A deficiency, which supports the hypothesis that high doses of synthetic retinoids may cause testicular degeneration through interference of normal retinol homeostasis.
- Published
- 1991
31. Comparative endotoxin-induced hepatic injury in young and aged rats
- Author
-
Roel J. Barelds, Michael A. Horan, Dick Knook, Stephen K. Durham, and Adriaan Brouwer
- Subjects
Aging ,medicine.medical_specialty ,Pathology ,Platelet Aggregation ,Kupffer Cells ,Neutrophils ,Increased Phagocytosis ,Cell ,Fibrin ,Pathology and Forensic Medicine ,Microcirculation ,Phagocytosis ,Rats, Inbred BN ,Internal medicine ,medicine ,Animals ,Humans ,Platelet ,Aspartate Aminotransferases ,Diminution ,biology ,business.industry ,Liver Diseases ,Alanine Transaminase ,Rats ,Endotoxins ,Endothelial stem cell ,Endocrinology ,medicine.anatomical_structure ,Liver ,Coagulation ,biology.protein ,Female ,Disease Susceptibility ,Chemical and Drug Induced Liver Injury ,business - Abstract
Recent studies have demonstrated that aged rats are more susceptible to the lethal effects of endotoxin (ET) than young rats. The early (15 min to 7 h) hepatic ultrastructural and biochemical changes induced by ET in young (6 months) and aged (24 months) rats were evaluated to elucidate cell populations and/or the mechanisms that may be responsible for the previously observed differential effects. Aged rats given ET had significantly increased numbers of neutrophils in hepatic sinusoids at 30 min and thereafter as compared with ET-treated young rats. Morphologic evidence of coagulation within hepatic sinusoids, including aggregates of fibrin enmeshed among polymorphonuclear leukocytes and platelet aggregates, was frequently observed in ET-treated aged rats but not in ET-treated young rats. In contrast, Kupffer cells of ET-treated young rats frequently contained phagocytized neutrophils and platelets, whereas this phenomenon was rarely observed in Kupffer cells of ET-treated aged rats. Hepatocellular morphologic injury was more pronounced and occurred at earlier time periods in ET-treated aged rats, and was accompanied by significant increase in hepatic transaminases. ET-treated aged rats had an earlier onset and greater severity of endothelial cell injury than did ET-treated young rats. The results of this study indicate a greater aggregation of blood elements in the hepatic sinusoids of aged rats following the intravenous administration of ET, which suggests that a greater diminution in microcirculation was induced in aged rats by ET. Additionally, the increased phagocytosis of inflammatory cells by Kupffer cells of young rats may be a mechanism which affords protection against endotoxin-induced lethality.
- Published
- 1990
32. Elementary Predictive Toxicology for Advanced Applications
- Author
-
Laura Custer, Greg M. Pearl, Stephen K. Durham, and Constantine Kreatsoulas
- Subjects
Legacy data ,Computer science ,Predictive toxicology ,computer.software_genre ,Data science ,Expert system ,PEARL (programming language) ,Informatics ,Applied mathematics ,Throughput (business) ,computer ,Limited resources ,computer.programming_language ,Pace - Abstract
As the pace of pharmaceutical drug discovery quickens and greater numbers of preclinical candidates are identified using combinatorial and other high throughput methods, the demand on safety assessment assays increases. As most in vitro toxicology assays are, at best, medium throughput, it is readily apparent that rapid in silico assessment protocols must be developed and validated for their use in the early discovery phase. No strangers to the increased demand for accurate safety assessments of candidate compounds and the additional constraints imposed by limited resources, regulatory agencies have long been at the forefront of utilizing and championing computational methods. As regulatory databases of safety information are populated and legacy data incorporated, methods to utilize this data to extract meaningful information must be developed and validated. As this is not intended to be an exhaustive review of all in silico tools for toxicology assessment, the reader is referred to a number of recent articles which do an outstanding job of summarizing the algorithms, benefits and shortcomings of many of the commercial packages available (Pearl, Livingston-Carr et al. 2001; Greene 2002; Snyder, Pearl et al. 2004).
- Published
- 2007
33. Lobucavir-induced proliferative changes in mice
- Author
-
Mark G. Mense, Stephen K. Durham, and Jochen Woicke
- Subjects
Ganciclovir ,Male ,Pathology ,medicine.medical_specialty ,Guanine ,Anemia ,Anti-HIV Agents ,Carcinogenicity Tests ,Longevity ,Physiology ,Administration, Oral ,Neutropenia ,Biology ,Toxicology ,Pathology and Forensic Medicine ,Zidovudine ,Mice ,medicine ,Carcinoma ,Animals, Outbred Strains ,Animals ,Hyperplasia ,Nucleoside analogue ,Dose-Response Relationship, Drug ,Cell Biology ,General Medicine ,Neoplasms, Experimental ,medicine.disease ,Peripheral neuropathy ,Carcinogens ,Carcinoma, Squamous Cell ,Female ,Nucleoside ,medicine.drug - Abstract
Nucleoside analogues are used in the treatment of viral infections, including those caused by human immunodeficiency virus, cytomegalovirus, and herpes virus. These drugs are beneficial in the treatment of human disease, but are associated with toxicities that often limit their intended therapeutic use, including anemia, neutropenia, peripheral neuropathy, and myopathy. Some of these compounds have been reported to be carcinogenic in rodents. To investigate the carcinogenic potential of lobucavir, a nucleoside analogue, three groups of 60 male and female mice were orally administered lobucavir at daily doses of 10, 50, and 250 mg/kg (males) or 30, 150, and 750 mg/kg (females) over a period of 104 weeks. Two identical groups of 60 male and female mice each served as controls. The morphology and the incidence of neoplasms is described and compared with the tumor spectrum of other nucleoside analogues. Light microscopically, lobucavir-induced neoplastic lesions consisted of upper digestive tract squamous cell neoplasia in males and females; cervical, vaginal, and cutaneous squamous cell neoplasia in females; and Hardarian gland adenomas and adenocarcinomas in male mice. These results suggest that long-term administration of lobucavir causes neoplasia in mice, the spectrum of which resembles that observed after long-term administration of zidovudine or ganciclovir.
- Published
- 2007
34. Predictive Mutagenicity Computer Models
- Author
-
Stephen K. Durham, Laura Custer, and Constantine Kreatsoulas
- Published
- 2007
35. Application of a probabilistic method for the determination of drug-induced QT prolongation in telemetered cynomolgus monkeys: effects of moxifloxacin
- Author
-
Henry H. Holzgrefe, Lewis V. Buchanan, Stephen K. Durham, Icilio Cavero, and Michael Gill
- Subjects
Male ,Moxifloxacin ,Cmax ,Blood Pressure ,Toxicology ,QT interval ,Body Temperature ,Electrocardiography ,Pharmacokinetics ,Anti-Infective Agents ,Heart Conduction System ,Heart Rate ,Heart rate ,medicine ,Repolarization ,Heart rate variability ,Animals ,Telemetry ,Aorta ,Pharmacology ,Aza Compounds ,Models, Statistical ,business.industry ,Drug-induced QT prolongation ,Long QT Syndrome ,Macaca fascicularis ,Anesthesia ,Data Interpretation, Statistical ,Quinolines ,Female ,business ,medicine.drug ,Fluoroquinolones - Abstract
Introduction: Moxifloxacin is the most widely used positive reference agent in clinical cardiac repolarization safety studies, but it has not been characterized in the cynomolgus monkey. This important experimental animal species exhibits pronounced heart rate variability, complicating the temporal evaluation of QT interval data. Methods: Digitized epicardial ECGs and aortic blood pressures were collected for 20 h in telemetered cynomolgus monkeys (n = 6) following the administration of either vehicle or moxifloxacin (10 or 50 mg/kg, p.o.). Moxifloxacin plasma concentrations were determined 4 h postdose. ECG intervals were analyzed by computerized algorithms. Individual probabilistic QT rate-corrections (QTc) were derived from the slopes of predose log-transformed QT–RR data where each QT value was the mean of > 250 beats/RR increment. The resulting QTc was used to determine the repolarization effects of moxifloxacin, expressed as the placebo-adjusted change in QTc (ΔQTc), and as the integrated response from 0 to 12 h (AUC0 → 12) postdose. Results: No ΔQTc effect was produced by 10 mg/kg moxifloxacin. However, moxifloxacin (50 mg/kg; 5.86 ± 0.5 μg/mL Cmax) significantly prolonged the RR interval by 50 to 112 ms from 3.5 to 7.5 h postdose and ΔQTc by ≥ 7.2 ms from 1.83 to 9.17 h, with a maximal ΔQTc effect of + 26.4 ms. No notable effects on either systemic blood pressure or body temperature occurred with either dose. Discussion: Probabilistic QT rate-corrections appear to have eliminated the confounding effects of heart rate, provided for a stable QTc baseline, and enabled the demonstration of an exposure-dependent QTc prolongation by moxifloxacin. The duration and magnitude of the QTc effect paralleled moxifloxacin pharmacokinetics, and Cmax values were similar to those achieved clinically in thorough QT/QTc studies. Thus, novel probabilistic QT rate-corrections may offer highly robust assessments of repolarization risk in both nonclinical and clinical investigations.
- Published
- 2006
36. Novel probabilistic method for precisely correcting the QT interval for heart rate in telemetered dogs and cynomolgus monkeys
- Author
-
Stephen K. Durham, Dennis E. Burkett, Henry H. Holzgrefe, William Warner, Icilio Cavero, Michael Gill, Lewis V. Buchanan, and Carol Gleason
- Subjects
Male ,Population ,RR interval ,Toxicology ,QT interval ,Electrocardiography ,Probabilistic method ,Dogs ,Heart Rate ,Heart rate ,Statistics ,medicine ,Repolarization ,Animals ,Telemetry ,education ,Mathematics ,Pharmacology ,education.field_of_study ,Models, Statistical ,medicine.diagnostic_test ,Circadian Rhythm ,Long QT Syndrome ,Macaca fascicularis ,Data Interpretation, Statistical ,Calibration ,Female ,Ecg lead ,Algorithms - Abstract
Introduction: QT intervals are not regulated on a beat-to-beat cadence, but are strongly influenced by the preceding heart rate history (hysteresis). ECG sampling, when performed over sufficiently long periods, results in the detection of ranges of different QT values for each discrete RR interval. Given the potential impact of QT hysteresis in QT interval rate-correction procedures, we hypothesized that, physiologically, the QT interval exists as a probabilistic variable where the exact value corresponding to any RR interval is precisely estimated from the associated QT population. Methods:Digital ECGs were collected for 18–21 h in telemetered dogs (n = 7) and cynomolgus monkeys (n = 7) employing epicardial ECG leads for accurate Tend detection, and analyzed by computerized algorithms. Descriptive statistics were calculated for raw QT values in 10 ms RR increments. Individual rate-corrected QT (QTc) formulae were derived from the slopes of log-transformed QT–RR data where each QT point was the mean of > 250 beats/RR increment. The aptness of this QTc model was assessed by residual analysis. Results:Beat-to-beat ECG analysis demonstrated that for all discrete cycle lengths, the associated raw QT intervals were normally distributed populations, spanning approximately 30–40 and 45–100 ms in the dog and cynomolgus monkey, respectively. In both species, QTc was stable (≤ 5 ms variation) over all physiological RR intervals. Discussion:The probabilistic treatment of raw QT interval populations natively associated to any RR interval provides hysteresis-free raw QT estimates which can be accurately modeled, allowing the derivation of a precise QTc value. Previous unawareness of the probabilistic nature of the QT interval explains the historical failure of numerous QT rate-correction formulae to correctly solve this scientific issue. Importantly, QT distribution analysis has the potential to provide, for the first time, a universal and sensitive method for QT heart rate-correction, providing a robust method for nonclinical and clinical cardiac safety investigations of repolarization delay.
- Published
- 2006
37. Probabilistic neural network multiple classifier system for predicting the genotoxicity of quinolone and quinoline derivatives
- Author
-
Linnan He, Laura L. Custer, Greg M. Pearl, Constantine Kreatsoulas, Peter C. Jurs, and Stephen K. Durham
- Subjects
medicine.drug_class ,Stereochemistry ,Mutagenicity Tests ,Quinoline ,General Medicine ,Computational biology ,Predictive toxicology ,Quinolones ,Toxicology ,medicine.disease_cause ,Quinolone ,Multiple classifier ,Ames test ,chemistry.chemical_compound ,Probabilistic neural network ,Structure-Activity Relationship ,chemistry ,Mutagenesis ,medicine ,Animals ,Neural Networks, Computer ,Carcinogen ,Genotoxicity ,Mutagens - Abstract
Quinolone and quinoline are known to be liver carcinogens in rodents, and a number of their derivatives have been shown to exhibit mutagenicity in the Ames test, using Salmonella typhimurium strain TA 100 in the presence of S9. Both the carcinogenicity and the mutagenicity of quinolone and quinoline derivatives, as determined by SAS, can be attributed to their genotoxicity potential. This potential, which is measured by genotoxicity tests, is a good indication of carcinogenicity and mutagenicity because compounds that are positive in these tests have the potential to be human carcinogens and/or mutagens. In this study, a collection of quinolone and quinoline derivatives' carcinogenicity is determined by qualitatively predicting their genotoxicity potential with predictive PNN (probabilistic neural network) classification models. In addition, a multiple classifier system is also developed to improve the predictability of genotoxicity. Superior results are seen with the multiple classifier system over the individual PNN classification models. With the multiple classifier system, 89.4% of the quinolone derivatives were predicted correctly, and higher predictability is seen with the quinoline derivatives at 92.2% correct. The multiple classifier system not only is able to accurately predict the genotoxicity but also provides an insight about the main determinants of genotoxicity of the quinolone and quinoline derivatives. Thus, the PNN multiple classifier system generated in this study is a beneficial contributor toward predictive toxicology in the design of less carcinogenic bioactive compounds.
- Published
- 2005
38. Development of the ICH guidelines for Immunotoxicology Evaluation of Pharmaceuticals Using a Survey of Industry Practices
- Author
-
Kenneth L. Hastings, James L. Weaver, Naohisa Tsutsui, Peter Ulrich, Hirofumi Kusunoki, Jan Willem van der Laan, Henk Van Loveren, S. Spanhaak, Jean-Marc Vidal, Jennifer Sims, Stephen K. Durham, Tibor I. Matula, Jun-ichi Sawada, Thomas T. Kawabata, Kazuichi Nakamura, Osamu Fueki, Shigeru Hisada, Gezondheidsrisico Analyse en Toxicologie, and RS: NUTRIM School of Nutrition and Translational Research in Metabolism
- Subjects
medicine.medical_specialty ,business.industry ,Initial screen ,Immunology ,Guideline ,Immunotoxicology ,Pharmacology ,Immune modulation ,Toxicology ,Toxicology studies ,Immune Function Testing ,Internal medicine ,medicine ,Dosing ,business ,Pharmaceutical industry - Abstract
An anonymous survey of pharmaceutical industry practices for immunotoxicology evaluation was conducted. This was in support of the development of the guideline on the preclinical evaluation of unintended modulation of the immune system for the International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use. The survey was conducted in two phases in 2003 and 2004. A total of 64 responses were received of which 45 were included in the formal evaluation. The remaining compounds were excluded because they were cytotoxic anti-neoplastic drugs (N = 7), or due to insufficient information (N = 12). The purpose of the survey was to gather data on the correlation between routine toxicology studies (RTS) and additional immunotoxicological studies (AIS). The results of the survey were evaluated by the Expert Working Group (EWG) and classified as to positive or negative findings in RTS and AIS. The results of the survey showed that for 27 of 45 compounds (60%), the RTS and AIS endpoints were in agreement. In 12 of 45 cases (27%), the RTS endpoints showed immune modulation not observed in the AIS assays. Finally for 6 of 45 drugs (13%) a response was seen with the AIS methods where no significant effect was observed in the RTS endpoints. Length of dosing and the number of tests evaluated were similar in all groups. The groups where RTS detected signs of immunosuppression were more likely to have been dosed at or above MTD. This data contributed to the consensus in the EWG that routine immune function testing as an initial screen for all new drugs is not required. Instead, a weight-of-evidence approach including RTS and other causes for concern is recommended to identify the need for additional immunotoxicity studies.
- Published
- 2005
39. Role of tumor necrosis factor receptor 1 (p55) in hepatocyte proliferation during acetaminophen-induced toxicity in mice
- Author
-
Jeffrey D. Laskin, Jennie A. Brittingham, Donna M. Dambach, Hawjyh Chiu, Stephen K. Durham, Debra L. Laskin, and Carol R. Gardner
- Subjects
Cyclin-Dependent Kinase Inhibitor p21 ,Male ,STAT3 Transcription Factor ,Cyclin A ,Mice, Transgenic ,Toxicology ,Receptors, Tumor Necrosis Factor ,Mice ,Phosphatidylinositol 3-Kinases ,Cyclin D1 ,Cyclin-dependent kinase ,Antigens, CD ,Cyclins ,Proto-Oncogene Proteins ,medicine ,CDC2-CDC28 Kinases ,Animals ,Protein kinase B ,Acetaminophen ,Pharmacology ,biology ,digestive, oral, and skin physiology ,Cyclin-dependent kinase 2 ,Cyclin-Dependent Kinase 2 ,Cyclin-Dependent Kinase 4 ,respiratory system ,Cell cycle ,Analgesics, Non-Narcotic ,Immunohistochemistry ,Cyclin-Dependent Kinases ,Up-Regulation ,DNA-Binding Proteins ,Mice, Inbred C57BL ,medicine.anatomical_structure ,Liver ,Receptors, Tumor Necrosis Factor, Type I ,Hepatocyte ,biology.protein ,Cancer research ,Hepatocytes ,Trans-Activators ,Tumor necrosis factor receptor 1 ,Cell Division ,Signal Transduction - Abstract
Hepatocyte proliferation represents an important part of tissue repair. In these studies, TNF receptor 1 (TNFR1) knockout mice were used to analyze the role of TNF-alpha in hepatocyte proliferation during acetaminophen-induced hepatotoxicity. Treatment of wild-type (WT) mice with acetaminophen (300 mg/kg) resulted in centrilobular hepatic necrosis. This was associated with proliferation of hepatocytes surrounding the damaged areas, which was evident at 24 h. The cell cycle regulatory proteins, cyclin D1 and cyclin A, were also up regulated in hepatocytes. In contrast, in TNFR1-/- mice, which exhibit exaggerated acetaminophen hepatotoxicity, hepatocyte proliferation, and expression of cyclin D1 and cyclin A, as well as the cyclin dependent kinases, Cdk4 and Cdk2, were reduced. The cyclin-dependent kinase inhibitor p21 was also induced in the liver following acetaminophen administration. This was greater in TNFR1-/- mice compared to WT mice. To investigate mechanisms mediating the reduced hepatic proliferative response of TNFR1-/- mice, we analyzed phosphatidyl inositol-3-kinase (PI-3K) signaling. In both WT and TNFR1-/- mice, acetaminophen caused a rapid increase in total PI-3K within 3 h. Acetaminophen also increased phosphorylated PI-3K, but this was delayed 6-12 h in TNFR1-/- mice. Expression of Akt, a downstream target of PI-3K, was increased in both WT and TNFR1-/- mice in response to acetaminophen. However, the increase was greater in WT mice. Acetaminophen-induced expression of phosphorylated STAT3, a key regulator of cytokine-induced hepatocyte proliferation, was also delayed in TNFR1-/- mice relative to WT. These data suggest that TNF-alpha signaling through TNFR1 is important in regulating hepatocyte proliferation following acetaminophen-induced tissue injury. Delayed cytokine signaling may account for reduced hepatocyte proliferation and contribute to exaggerated acetaminophen-induced hepatotoxicity in TNFR1-/- mice.
- Published
- 2003
40. Role of p55 tumor necrosis factor receptor 1 in acetaminophen-induced antioxidant defense
- Author
-
Jeffrey D. Laskin, Jennie A. Brittingham, Hawjyh Chiu, Donna M. Dambach, Carol R. Gardner, Stephen K. Durham, and Debra L. Laskin
- Subjects
Male ,Physiology ,Ratón ,medicine.medical_treatment ,medicine.disease_cause ,Antioxidants ,Receptors, Tumor Necrosis Factor ,Proinflammatory cytokine ,Mice ,Necrosis ,Antigens, CD ,Physiology (medical) ,medicine ,Animals ,Transcription factor ,Acetaminophen ,Mice, Knockout ,Hepatology ,business.industry ,Superoxide Dismutase ,Gastroenterology ,NF-kappa B ,Membrane Proteins ,Alanine Transaminase ,respiratory system ,Glutathione ,Mice, Inbred C57BL ,Transcription Factor AP-1 ,Cytokine ,Liver ,Receptors, Tumor Necrosis Factor, Type I ,Enzyme Induction ,Immunology ,Heme Oxygenase (Decyclizing) ,Cancer research ,Tumor necrosis factor alpha ,Tumor necrosis factor receptor 1 ,business ,Oxidative stress ,Heme Oxygenase-1 ,medicine.drug - Abstract
Tumor necrosis factor (TNF)-alpha is a macrophage-derived proinflammatory cytokine implicated in hepatotoxicity. In the present studies, p55 TNF receptor 1 (TNFR1) -/- mice were used to assess the role of TNF-alpha in acetaminophen-induced antioxidant defense. Treatment of wild-type (WT) mice with acetaminophen (300 mg/kg) resulted in centrilobular hepatic necrosis and increased serum alanine transaminases. This was correlated with a rapid depletion of hepatic glutathione (GSH). Whereas in WT mice GSH levels returned to control after 6-12 h, in TNFR1-/- mice recovery was delayed for 48 h. Delayed induction of heme oxygenase-1 and reduced expression of CuZn superoxide dismutase were also observed in TNFR1-/- compared with WT mice. This was associated with exaggerated hepatotoxicity. In WT mice, acetaminophen caused a time-dependent increase in activator protein-1 nuclear binding activity and in c-Jun expression. This response was significantly attenuated in TNFR1-/- mice. Constitutive NF-kappaB binding activity was detectable in livers of both WT and TNFR1-/- mice. A transient decrease in this activity was observed 3 h after acetaminophen in WT mice, followed by an increase that was maximal after 6-12 h. In contrast, in TNFR1-/- mice, acetaminophen-induced decreases in NF-kappaB activity were prolonged and did not return to control levels for 24 h. These data indicate that TNF-alpha signaling through TNFR1 plays an important role in regulating the expression of antioxidants in this model. Reduced generation of antioxidants may contribute to the increased sensitivity of TNFR1-/- mice to acetaminophen.
- Published
- 2003
41. Predicting the genotoxicity of thiophene derivatives from molecular structure
- Author
-
Laura L. Custer, Stephen K Durham, Greg M. Pearl, Peter C. Jurs, and Philip D. Mosier
- Subjects
Models, Molecular ,Thiophenes ,Toxicology ,medicine.disease_cause ,Polar surface area ,Probabilistic neural network ,Structure-Activity Relationship ,medicine ,Escherichia coli ,SOS Response, Genetics ,Mathematics ,Molecular Structure ,business.industry ,Discriminant Analysis ,Pattern recognition ,General Medicine ,Linear discriminant analysis ,SOS chromotest ,Binary classification ,Mutagenesis ,Simulated annealing ,Artificial intelligence ,business ,Classifier (UML) ,Genotoxicity ,DNA Damage ,Mutagens - Abstract
We report several binary classification models that directly link the genetic toxicity of a series of 140 thiophene derivatives with information derived from the compounds' molecular structure. Genetic toxicity was measured using an SOS Chromotest. IMAX (maximal SOS induction factor) values were recorded for each of the 140 compounds both in the presence and in the absence of S9 rat liver homogenate. Compounds were classified as genotoxic if IMAX >or= 1.5 in either test or nongenotoxic if IMAX < 1.5 for both tests. The molecular structures were represented by numerical descriptors that encoded the topological, geometric, electronic, and polar surface area properties of the thiophene derivatives. The classification models used were linear discriminant analysis (LDA), k-nearest neighbor classification (k-NN), and the probabilistic neural network (PNN). These were used in conjunction with either a genetic algorithm or a generalized simulated annealing to find optimal subsets of descriptors for each classifier. The quality of the resulting models was determined by the number of misclassified compounds, with preference given to models that produced fewer false negative classifications. Model sizes ranged from seven descriptors for LDA to three descriptors for k-NN and PNN. Very good classification results were obtained with all three classifiers. Classification rates for the LDA, k-NN, and PNN models were 80, 85, and 85%, respectively, for the prediction set compounds. Additionally, a consensus model was generated that incorporated all three of the basic model types. This consensus model correctly predicted the genotoxicity of 95% of the prediction set compounds.
- Published
- 2003
42. Reduced hepatotoxicity of acetaminophen in mice lacking inducible nitric oxide synthase: potential role of tumor necrosis factor-alpha and interleukin-10
- Author
-
Carol R, Gardner, Jeffrey D, Laskin, Donna M, Dambach, Michael, Sacco, Stephen K, Durham, Mary K, Bruno, Steven D, Cohen, Marion K, Gordon, Donald R, Gerecke, Peihong, Zhou, and Debra L, Laskin
- Subjects
Mice, Knockout ,Tumor Necrosis Factor-alpha ,Liver Diseases ,Connective Tissue Growth Factor ,Gene Expression ,Nitric Oxide Synthase Type II ,Guanidines ,Immediate-Early Proteins ,Interleukin-10 ,Mice ,Liver ,Matrix Metalloproteinase 9 ,Animals ,Intercellular Signaling Peptides and Proteins ,RNA, Messenger ,Chemical and Drug Induced Liver Injury ,Nitric Oxide Synthase ,Gene Deletion ,Acetaminophen ,Protein Binding - Abstract
Macrophage-derived inflammatory mediators have been implicated in tissue injury induced by a number of hepatotoxicants. In the present studies, we used transgenic mice with a targeted disruption of the gene for inducible nitric oxide synthase (NOS II) to analyze the role of nitric oxide in inflammatory mediator production in the liver and in tissue injury induced by acetaminophen. Treatment of wild-type mice with acetaminophen (300 mg/kg) resulted in centrilobular hepatic necrosis, which was evident within 3 h and reached a maximum at 18 h. This was correlated with NOS II expression and nitrotyrosine staining of the liver, which was most prominent after 6 h. Expression of mRNA for tumor necrosis factor-alpha (TNF-alpha), interleukin-10 (IL-10), matrix metalloproteinase-9, and connective tissue growth factor (CTGF) also increased in the liver following acetaminophen treatment of wild-type mice. NOS II knockout mice were found to be less sensitive to the hepatotoxic effects of acetaminophen than wild-type mice. This did not appear to be due to differences in acetaminophen-induced glutathione depletion or adduct formation. In NOS II knockout mice treated with acetaminophen, hepatic expression of TNF-alpha, as well as CTGF, was significantly increased compared to wild-type mice. In contrast, IL-10 expression was reduced. These data demonstrate that nitric oxide is important in hepatotoxicity induced by acetaminophen. Moreover, some of its effects may be mediated by altering production of pro- and antiinflammatory cytokines and proteins important in tissue repair.
- Published
- 2002
43. Integration of computational analysis as a sentinel tool in toxicological assessments
- Author
-
Greg M. Pearl, Stephen K. Durham, and Sondra Livingston-Carr
- Subjects
Computational model ,Drug-Related Side Effects and Adverse Reactions ,Computer science ,Drug discovery ,food and beverages ,Computational Biology ,Reproducibility of Results ,General Medicine ,Pharmacology ,Toxicology ,Teratogens ,Risk analysis (engineering) ,Drug Discovery ,Models, Animal ,Carcinogens ,Animals ,Humans ,Computational analysis ,Software ,Mutagens - Abstract
Computational toxicity modeling can have significant impact in the drug discovery process, especially when utilized as a sentinel filter for common drug safety liabilities, such as mutagenicity, carcinogenicity and teratogenicity. This review will focus on the strengths and limitations of the current computational models for predicting these drug safety liabilities, and the various strategies for incorporating these predictive models into the drug discovery process.
- Published
- 2002
44. Risk AssessmentThe Changing Paradigm
- Author
-
James A. Swenberg and Stephen K. Durham
- Subjects
Risk perception ,Engineering ,Risk analysis (engineering) ,business.industry ,Process (engineering) ,Management science ,Risk analysis (business) ,Risk management tools ,Factor analysis of information risk ,Risk assessment ,business ,Hazard ,Risk management - Abstract
This chapter discusses the changing paradigm of the risk assessment. Veterinary pathologists and toxicologists participate in the risk assessment process on a daily basis. The pathologist, together with the input from colleagues in toxicology, initially identifies the potential adverse effects of chemicals and drugs in laboratory animals, defines the dose response of the effects, and then determines whether they are likely to express themselves in humans. In order to ascertain an accurate conclusion in the risk assessment process, broad scientific knowledge with biologically based mechanistic information is required. Mechanism helps to determine whether the hazard develops in humans or not; gives quantitative information to suggest that risk is more or less likely to occur; and helps identify subpopulations that are at greater or lesser risk. Thus, there is a critical need for a scientific understanding of mechanism to reduce the extent of uncertainty associated with the assessment of risk. Risk management is the decision-making process that formulates policy actions designed to reduce the probability that the hazard will be expressed. Different skill sets are required for risk assessment and risk management. In addition to evaluating risk estimates, risk managers must also consider statutory, economic, social, and political factors. The perception of risk and its impact varies greatly among societies.
- Published
- 2002
45. Long-term entecavir treatment results in sustained antiviral efficacy and prolonged life span in the woodchuck model of chronic hepatitis infection
- Author
-
Junius M. Clark, Lawrence Corey, Meei-Li Huang, Richard J. Colonno, Burt Rose, Steven Locarnini, Bud C. Tennant, Lucinda Lamb, Ivette Medina, Margaret Littlejohn, Eugene V. Genovesi, and Stephen K. Durham
- Subjects
medicine.medical_specialty ,Carcinoma, Hepatocellular ,Guanine ,Time Factors ,viruses ,Biology ,Virus Replication ,Gastroenterology ,Antiviral Agents ,Virus ,Hepatitis B, Chronic ,Liver Neoplasms, Experimental ,Orthohepadnavirus ,Internal medicine ,medicine ,Immunology and Allergy ,Animals ,Hepatitis B Virus, Woodchuck ,Humans ,Hepatitis ,Hepatitis B Surface Antigens ,Nucleoside analogue ,Woodchuck hepatitis virus ,Entecavir ,medicine.disease ,biology.organism_classification ,Virology ,digestive system diseases ,Disease Models, Animal ,Infectious Diseases ,Hepadnaviridae ,Liver ,Hepatocellular carcinoma ,Marmota ,DNA, Viral ,DNA, Circular ,medicine.drug - Abstract
Entecavir (ETV) is a guanosine nucleoside analogue with potent antiviral efficacy in woodchucks chronically infected with woodchuck hepatitis virus. To explore the consequences of prolonged virus suppression, woodchucks received ETV orally for 8 weeks and then weekly for 12 months. Of the 6 animals withdrawn from therapy and monitored for an additional 28 months, 3 had a sustained antiviral response and had no evidence of hepatocellular carcinoma (HCC). Of the 6 animals that continued on a weekly ETV regimen for an additional 22 months, 4 exhibited serum viral DNA levels near the lower limit of detection for >2 years and had no evidence of HCC. Viral antigens and covalently closed circular DNA levels in liver samples were significantly reduced in all animals. ETV was well tolerated, and there was no evidence of resistant variants. On the basis of historical data, long-term ETV treatment appeared to significantly prolong the life of treated animals and delay the emergence of HCC.
- Published
- 2001
46. Oncostatin M: development of a pleiotropic cytokine
- Author
-
Karen K. Berry, Davidson Thomas J, John F. MacMaster, Bharat Danle, James Loy, and Stephen K. Durham
- Subjects
medicine.medical_specialty ,Lipopolysaccharide ,040301 veterinary sciences ,medicine.medical_treatment ,Anti-Inflammatory Agents ,Antineoplastic Agents ,Oncostatin M ,Toxicology ,030226 pharmacology & pharmacy ,Pathology and Forensic Medicine ,0403 veterinary science ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Internal medicine ,medicine ,Animals ,Humans ,Serum amyloid A ,Interleukin 6 ,Molecular Biology ,Inflammation ,biology ,business.industry ,Experimental autoimmune encephalomyelitis ,04 agricultural and veterinary sciences ,Cell Biology ,medicine.disease ,Disease Models, Animal ,Cytokine ,Endocrinology ,chemistry ,Toxicity ,biology.protein ,Cytokines ,Tumor necrosis factor alpha ,business ,Peptides - Abstract
Oncostatin M (OM) is a member of the interleukin-6 (IL-6) cytokine subfamily. The binding of OM to its receptor initiates signal transduction through JAK-signal transducers and activators of transcription (STAT) pathways and activates transcription activators through mitogen-activated protein (MAP) kinases. Results of in vitro assays documented that OM modulates cytokine expression and alters the production of proteases that down-regulate inflammation. Administration of OM to lipopolysaccharide (LPS)-challenged mice lowered serum tumor necrosis factor-alpha (TNF-alpha) levels and decreased the lethal effects of LPS administration. OM also reduced inflammation in animal models of human disease, including inflammatory bowel disease, antibody-induced arthritis, and experimental autoimmune encephalomyelitis. Preclinical safety studies have been conducted in the mouse and monkey. Mice were administered OM (subcutaneously) at 72, 360, or 1,560 micrograms/kg/day in a 2-wk toxicity study. Decreased body weights occurred at 1,560 micrograms/kg. Drug-related changes at 360 and 1,560 micrograms/kg consisted of dermal irritation at the injection site, leukopenia, and thymic lymphoid depletion; all changes were reversible following a 2-wk recovery period. In a 2-wk subcutaneous study in monkeys, OM was administered at 1, 5, 15, 45, or 150 micrograms/kg/day. At all doses there was reversible, transient inappetence and dermal irritation at the injection site. Drug-related changes at 5, 15, 45, and 150 micrograms/kg consisted of reversible elevations in both serum amyloid A and IL-6, and reversible thymic lymphoid depletion. Transient increases in body temperature occurred at 15, 45, and 150 micrograms/kg. The observed spectrum of immunomodulatory effects suggests that OM may have therapeutic utility in treating chronic inflammatory diseases.
- Published
- 1999
47. Enhanced reduction of atherosclerosis in hamsters treated with pravastatin and captopril: ACE in atheromas provides cellular targets for captopril
- Author
-
Nancy L. Goller, Sophie Beyer, Gunnar Aberg, Stephen K. Durham, Maria T. Valentine, Ron Recce, and Mark C. Kowala
- Subjects
Male ,medicine.medical_specialty ,Captopril ,Arteriosclerosis ,Coenzyme A ,Lipoproteins ,Angiotensin-Converting Enzyme Inhibitors ,Blood Pressure ,Reductase ,Peptidyl-Dipeptidase A ,chemistry.chemical_compound ,Internal medicine ,Cricetinae ,medicine ,Animals ,RNA, Messenger ,Pravastatin ,Pharmacology ,biology ,Mesocricetus ,business.industry ,Anticholesteremic Agents ,Hydroxymethylglutaryl-CoA reductase ,Immunohistochemistry ,Lipids ,Endocrinology ,Cholesterol ,chemistry ,Enzyme inhibitor ,ACE inhibitor ,HMG-CoA reductase ,biology.protein ,Cardiology and Cardiovascular Medicine ,business ,medicine.drug - Abstract
Inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase and angiotensin-converting enzyme (ACE) reduce experimental atherosclerosis by different mechanisms. To determine whether dual-drug therapy additively retards the progression of early lesions, control hyperlipidemic hamsters were compared with those treated with pravastatin, captopril, and pravastatin plus captopril. After 8 weeks of treatment, pravastatin (34 mg/kg/day) reduced plasma total cholesterol and triglycerides by 41 and 84%, respectively, whereas captopril (100 mg/kg/day) reduced normal blood pressure by 21%. The combination of pravastatin and captopril (33 and 100 mg/kg/day) decreased plasma total cholesterol and triglycerides by 44 and 84%, and blood pressure was decreased by 14%. In the aortic arch, pravastatin reduced macrophage-foam cell size and fatty streak area by 21 and 31%, respectively, whereas captopril decreased macrophage-foam cell number and fatty streak area by 34 and 35%. Pravastatin plus captopril decreased macrophage-foam cell number, foam cell size, and fatty streak area by 38, 24, and 67%. ACE inhibitors were previously reported to retard atherosclerosis without affecting blood pressure, suggesting that these agents acted on the artery wall. Therefore the expression of arterial ACE was determined in normal and atherosclerotic hamster aortas. ACE messenger RNA (mRNA) and protein were detected in endothelial cells, intimal macrophage-foam cells and medial smooth-muscle cells of atherosclerotic arteries indicating an upregulation of ACE expression with hyperlipidemia and atherosclerosis. In conclusion, dual-therapy with pravastatin and captopril produced an additive reduction in fatty streak area compared with either drug alone and suggested that atherogenesis can be retarded beyond the level achieved with monotherapy. The presence of ACE in endothelial cells and intimal macrophage-foam cells provides cellular targets for captopril to directly modify the formation of early atherosclerotic lesions.
- Published
- 1998
48. HMG CoA reductase inhibitor-induced myotoxicity: pravastatin and lovastatin inhibit the geranylgeranylation of low-molecular-weight proteins in neonatal rat muscle cell culture
- Author
-
Barbara A. Masters, Stephen K. Durham, Oliver P. Flint, and Richard E. Gregg
- Subjects
Geranylgeranyl pyrophosphate ,Farnesyl pyrophosphate ,Mevalonic Acid ,Muscle Proteins ,Toxicology ,Tritium ,Rats, Sprague-Dawley ,chemistry.chemical_compound ,Geranylgeranylation ,Geranylgeraniol ,Prenylation ,Polyisoprenyl Phosphates ,Pregnancy ,medicine ,Animals ,Lovastatin ,Muscle, Skeletal ,Cells, Cultured ,Pravastatin ,Pharmacology ,biology ,Dose-Response Relationship, Drug ,Anticholesteremic Agents ,Rats ,Molecular Weight ,Cholesterol ,chemistry ,Biochemistry ,Animals, Newborn ,Isotope Labeling ,HMG-CoA reductase ,biology.protein ,Autoradiography ,Scintillation Counting ,lipids (amino acids, peptides, and proteins) ,Electrophoresis, Polyacrylamide Gel ,Female ,Hydroxymethylglutaryl-CoA Reductase Inhibitors ,Protein Processing, Post-Translational ,Sesquiterpenes ,medicine.drug ,Densitometry - Abstract
In previous studies, inhibition of cholesterol synthesis by HMG CoA reductase inhibitors (HMGRI) was associated with myotoxicity in cultures of neonatal rat skeletal myotubes, and rhabdomyolysis in rats, rabbits, and humans in vivo. In vitro myotoxicity was directly related to HMGRI-induced depletion of mevalonate, farnesol, and geranylgeraniol, since supplementation with these intermediate metabolites abrogated the toxicity. Both farnesol and geranylgeraniol are required for the posttranslational modification, or isoprenylation, of essential regulatory proteins in mammalian cells. The objective of the present study was to measure changes in protein isoprenylation in cultured neonatal rat skeletal muscle cells exposed for 24 hr to increasing concentrations of pravastatin or lovastatin. Proteins were labeled with [3H]mevalonate, [3H]farnesyl pyrophosphate (FPP), or [3H]geranylgeranyl pyrophosphate (GGPP), and then separated by SDS-PAGE and quantitated by scintillation counting and densitometry of autoradiographs. Mevalonate and FPP labeling of the majority of proteins increased in a concentration-dependent manner, even at concentrations greater than 2 microM lovastatin and 25 microM pravastatin that completely inhibited cholesterol synthesis. In contrast, mevalonate and FPP labeling of three protein bands with molecular weights of 26.6, 27.7, and 28.9 kDa was markedly inhibited at concentrations higher than 1 microM lovastatin and 400 microM pravastatin, which inhibited protein synthesis and disrupted myotube morphology after longer exposures in a previous study. In contrast, these proteins were equally well labeled by GGPP at all HMGRI concentrations tested, suggesting that isoprenylation of the 26.9-, 27.8-, and 28.9-kDa proteins requires geranylgeraniol. The results of this study indicate that HMGRI-induced myotoxicity is most likely related to reduced posttranslational modification of specific regulatory proteins by geranylgeraniol.
- Published
- 1997
49. Inhibition of cholesterol synthesis by squalene synthase inhibitors does not induce myotoxicity in vitro
- Author
-
Stephen K. Durham, Barbara A. Masters, Richard E. Gregg, and Oliver P. Flint
- Subjects
Squalene ,Geranylgeranyl pyrophosphate ,Mevalonic Acid ,Toxicology ,Butylamines ,Rats, Sprague-Dawley ,chemistry.chemical_compound ,Geranylgeraniol ,Pregnancy ,medicine ,Animals ,Prodrugs ,Lovastatin ,Enzyme Inhibitors ,Muscle, Skeletal ,Cells, Cultured ,Pravastatin ,Pharmacology ,Analysis of Variance ,biology ,L-Lactate Dehydrogenase ,Anticholesteremic Agents ,Farnesol ,Hydroxymethylglutaryl-CoA reductase ,Rats ,Cholesterol ,Farnesyl-Diphosphate Farnesyltransferase ,Biochemistry ,chemistry ,Animals, Newborn ,Enzyme inhibitor ,Protein Biosynthesis ,HMG-CoA reductase ,biology.protein ,lipids (amino acids, peptides, and proteins) ,Female ,Diterpenes ,Hydroxymethylglutaryl-CoA Reductase Inhibitors ,Sulfonic Acids ,medicine.drug - Abstract
The cholesterol-lowering HMG CoA reductase inhibitors (HMGRI), pravastatin and lovastatin, have been associated with skeletal myopathy in humans and in rats. In a previous in vitro study, HMGRI-induced changes in neonatal rat skeletal muscle cells were characterized by reversible inhibition of protein synthesis and loss of differentiated myotubes at concentrations markedly lower than those inducing enzyme leakage. Myotoxicity was determined to be directly related to inhibition of HMG CoA reductase, since mevalonate, the immediate product of HMG CoA reductase metabolism, abrogated the drug-induced changes. Farnesol, geranylgeraniol, and squalene are metabolites of mevalonate. Squalene, formed from farnesol by squalene synthase, is the first metabolite solely committed to cholesterol synthesis. In contrast, geranylgeraniol, formed by the addition of an isoprene group to farnesol, is the first metabolite uncommitted to cholesterol synthesis. The objective of the present study was to determine the role of inhibition of cholesterol synthesis in HMGRI-induced in vitro myotoxicity. HMGRI-treated neonatal rat skeletal muscle cultures were supplemented with farnesol and geranylgeraniol, and in another study, muscle cultures were exposed to two squalene synthase inhibitors (SSI), BMS-187745 and its prodrug ester, BMS-188494. Endpoints evaluated for both studies included protein synthesis ([ 3 H]leucine incorporation), total cellular protein (a measure of cell loss), intra- and extracellular lactate dehydrogenase activity (a measure of membrane integrity), cholesterol biosynthesis ([ 14 C]acetate incorporation), and morphology. HMG CoA reductase inhibitor-induced morphologic changes and inhibition of protein synthesis were significantly ameliorated by supplementation with farnesol and geranylgeraniol. In contrast to HMGRI-induced in vitro myotoxicity, SSI induced an irreversible, minimal cytotoxicity at close to maximum soluble concentrations. These results indicate that depletion of metabolites of geranylgeranyl pyrophosphate, and not inhibition of cholesterol synthesis, is the primary cause of HMG CoA reductase-induced myotoxicity.
- Published
- 1997
50. p50–NFκB Complexes Partially Compensate for the Absence of RelB: Severely Increased Pathology in p50^(-/-)relB^(-/-) Double-knockout Mice
- Author
-
Falk Weih, Stephen K. Durham, Rodrigo Bravo, William C. Sha, Debra S. Barton, and David Baltimore
- Subjects
Pathology ,medicine.medical_specialty ,P50 ,Lymphoid Tissue ,Immunology ,Transcription Factor RelB ,Inflammation ,Biology ,Article ,Mice ,Bone Marrow ,Proto-Oncogene Proteins ,medicine ,Animals ,Immunology and Allergy ,Abnormalities, Multiple ,Lymphocytes ,Lung ,B cell ,Mice, Knockout ,Macrophages ,Myocardium ,RELB ,NF-kappa B ,NF-kappa B p50 Subunit ,NFKB1 ,Phenotype ,medicine.anatomical_structure ,Gene Expression Regulation ,medicine.symptom ,Digestive System ,Protein Binding ,Transcription Factors - Abstract
RelB-deficient mice (relB(-/-)) have a complex phenotype including multiorgan inflammation and hematopoietic abnormalities. To examine whether other NF-kappaB/Rel family members are required for the development of this phenotype or have a compensatory role, we have initiated a program to generate double-mutant mice that are deficient in more than one family member. Here we report the phenotypic changes in relB(-/-) mice that also lack the p50 subunit of NF-kappaB (p50(-/-)). The inflammatory phenotype of p50(-/-)relB(-/-) double-mutant mice was markedly increased in both severity and extent of organ involvement, leading to premature death within three to four weeks after birth. Double-knockout mice also had strongly increased myeloid hyperplasia and thymic atrophy. Moreover, B cell development was impaired and, in contrast to relB(-/-) single knockouts, B cells were absent from inflammatory infiltrates. Both p50(-/-) and heterozygous relB(-/+) animals are disease-free. In the absence of the p50, however, relB(-/+) mice (p50(-/-)relB(-/+)) had a mild inflammatory phenotype and moderate myeloid hyperplasia. Neither elevated mRNA levels of other family members, nor increased kappaB-binding activities of NF-kappaB/Rel complexes could be detected in single- or double-mutant mice compared to control animals. These results indicate that the lack of RelB is, in part, compensated by other p50-containing complexes and that the "classical" p50-RelA-NF-kappaB activity is not required for the development of the inflammatory phenotype.
- Published
- 1997
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.